Substrate binding and catalysis by the pseudouridine synthases RluA and TruB by Keffer-Wilkes, Laura C.
University of Lethbridge Research Repository
OPUS http://opus.uleth.ca
Theses Arts and Science, Faculty of
2012
Substrate binding and catalysis by the
pseudouridine synthases RluA and TruB
Keffer-Wilkes, Laura Carole
Lethbridge, Alta. : University of Lethbridge, Dept. of Chemistry and Biochemistry, c2012
http://hdl.handle.net/10133/3253
Downloaded from University of Lethbridge Research Repository, OPUS
Substrate binding and catalysis by the pseudouridine synthases RluA and TruB 
 
 
 
Laura Carole Keffer-Wilkes 
B.Sc. University of Guelph, 2008 
 
 
 
A Thesis 
Submitted to the School of Graduate Studies 
of the University of Lethbridge 
in Partial Fulfilment of the 
Requirements for the Degree 
MASTER OF SCIENCE 
 
 
Department of Chemistry and Biochemistry 
University of Lethbridge 
LETHBRIDGE, ALBERTA, CANADA 
 
 
© Laura C. Keffer-Wilkes, 2012 
 
 
 
iii 
 
Abstract 
Pseudouridine is the most common RNA modification found in all forms of life. The exact 
role pseudouridines play in the cell is still relatively unknown. However, its extensive 
incorporation in functionally important areas of the ribosome and the fitness advantage 
provided to cells by pseudouridines implies that its presence is important for the cell. The 
enzymes responsible for this modification, pseudouridine synthases, vary greatly in 
substrate recognition mechanisms, but all enzymes supposedly share a universally 
conserved catalytic mechanism. Here, I analyze the kinetic mechanisms of 
pseudouridylation utilized by the exemplary pseudouridine synthase RluA in order to 
compare it with the previously determined rate of pseudouridylation of the pseudouridine 
synthase TruB. My results demonstrate that RluA has the same uniformly slow catalytic 
step as previously determined for TruB and TruA. This constitutes the first step towards 
identifying the catalytic mechanism of the pseudouridine synthase family. Additionally, it 
was my aim to identify the major determinants for RNA binding by pseudouridine 
synthases. By measuring the dissociation constants (KD) for substrate and product tRNA 
by nitrocellulose filtration assays, I showed that both tRNA species could bind with 
similar affinities. These binding studies also revealed that TruB’s interaction with the 
isolated T-arm is the major contact site contributing to the affinity of the enzyme to RNA. 
Finally, a new contact between tRNA and TruB’s PUA domain was identified which was 
not observed in the crystal structure. In summary, my results provide new insight into the 
common catalytic step of pseudouridine synthases and the specific interactions 
contributing to substrate binding by the enzyme TruB. These results will enable future 
studies on the kinetic mechanism of pseudouridine synthases, in particular the kinetics 
of substrate and product binding and release, as well as on the chemical mechanism of 
pseudouridine formation. 
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Chapter 1 – Introduction 
1.1 RNA in the Cell  
Ribonucleic acids (RNA) play many essential roles within the cell. During gene 
expression, messenger RNA (mRNA) is transcribed from the DNA genome and then 
translated by the ribosome into a polypeptide sequence. Notably, ribosomal RNA (rRNA) 
is the catalytic component of the ribosome (Noller et al., 1992). Additionally, transfer 
RNAs (tRNA) transport amino acid residues to the ribosomal A site during protein 
synthesis. Gene regulation can be achieved through micro RNA (miRNA) or small 
interfering RNA (siRNA) as part of the RNA-induced silencing complex (RISC) in the 
RNA interference pathway. Small nuclear RNAs (snRNA) are highly conserved 60- to 
300-nucleotide RNAs that are part of small nuclear ribonucleoproteins (snRNPs; see 
below) and are involved in splicing. Finally, small nucleolar RNAs (snoRNA) contribute to 
RNA biogenesis and are used as guide RNA templates in RNA modification. While some 
RNAs such as miRNA and siRNA require specific short ribonucleotide sequences for 
their roles in the cell, the common theme among many functional RNA species (e.g. 
tRNA and rRNA) is the requirement of a  three-dimensional structure in order to 
complete their functions. This can be achieved through specific primary sequences, as 
well as through enzyme-catalyzed modifications to existing ribonucleotides or by 
interaction with RNA chaperones or RNA-binding proteins. 
1.2 Pseudouridine  
All forms of RNA are comprised of the same four ribonucleotide components. A 
nucleobase is attached to a ribose sugar at the C1’ position, and phosphate groups are 
found at the 3’ and 5’ carbons of the sugar connecting the individual nucleotides by 
phosphodiester bonds. The bases in RNA differ only slightly from those found in DNA. 
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RNA contains the typical bases adenine, guanine, and cytosine also found in DNA. 
Additionally, RNA is comprised of the unmethylated form of thymine, uracil (U), which 
base pairs with adenine. In addition to these four nucleotides, modifications to the base 
and sugar moieties are commonly found in noncoding, functional RNAs, such as tRNA 
and rRNA. Nearly 100 naturally occurring RNA modifications have been described (Lane 
1998). Coding RNA (mRNA) can also be posttranscriptionally modified by the addition of 
the 5’ cap and 3’ poly-A tail. tRNA and rRNAs can have methyl groups attached to the 
endocyclic carbon (e.g. 2-methyladenosine), the endocyclic nitrogen (e.g. 1-
methyladenosine), and the exocyclic nitrogen (N6-methyladenosine)of the bases. 
Additionally, the exocyclic O2-ogygen of the ribose (e.g. 2’-O-methylribose) can be 
methylated. The most common RNA modifications  are pseudouridines (Lane, 1998). 
Pseudouridine was first identified in the 1950s and has commonly been called the fifth 
nucleotide (Davis and Allen, 1957). Pseudouridine is the C-glycosyl isomer of the N-
glycosyl nucleotide, uridine, and contains the only C-C glycosidic bond in RNA or DNA 
(Lane, 1998). The enhanced rotational freedom of the C-C bond over the N-C bond 
allows for greater conformational flexibility of the nucleoside (Figure 1; Davis, 1998). In 
pseudouridine, the N1 position is available for additional hydrogen bonding, potentially 
forming novel base pairing interactions (Charette and Gray, 2000). Arnez and Steitz 
(1994) observed in the crystal structure of tRNA(Gln) in complex with glutaminyl-tRNA 
synthetase and ATP, that the N1H imino group could coordinate a water molecule 
between the nucleobase and the phosphate backbone, resulting in an overall more rigid 
local tRNA structure. 
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Figure 1.1: Conversion of uridine to pseudouridine. The C1’ – N1 glycosidic bond of 
uridine (left) is broken, the base rotated, and a new C1’ – C5 glycosidic bond forms in 
pseudouridine (right). 
In solution, free pseudouridine tends to have a slight preference for the syn glycosyl 
conformation. This is in contrast to the anti conformation usually found in uridine and 
other nucleosides (Davis, 1998). When pseudouridine is incorporated into a 
polynucleotide chain however, only the anti configuration has been observed (Yarian et 
al., 1999). It is in this conformation that pseudouridine adopts the appropriate geometry 
to coordinate the water molecule between the N1 position and its 5’ phosphate 
connecting it to its neighbouring residue (Arnez and Steitz 1994). NMR, UV, and CD 
spectroscopy revealed that pseudouridine, as part of an oligoribonucleotide sequence, 
forms an A-form helical conformation with increased base stacking compared to the 
unmodified RNA (Davis, 1995). This improved base stacking has been proposed as the 
most important effect of pseudouridine on RNA structure stabilization (Davis, 1995). 
1.3 Pseudouridine in RNA 
Pseudouridines can be found in several functional RNAs. In eukaryotes, pseudouridines 
are an integral part of the spliceosomal machinery. The pre-mRNA initially transcribed 
from an organism’s genome contains both protein-coding exons and non-coding introns. 
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During splicing, the introns are removed and the exons are spliced together to form the 
mature mRNA strand. The spliceosome is a large, dynamic RNA-protein complex. As 
part of spliceosome assembly, uridyl-rich snRNAs form RNA-protein complexes called 
small nuclear ribonucleoproteins (snRNPs). Pseudouridines within these snRNAs are 
generally clustered in functionally important regions and are required for snRNP 
assembly and splicing. During spliceosome assembly, uridyl-rich snRNAs – U1, U2, U4, 
U5, and U6 associate with several protein components. Base-pairing between U1 and 
the 5’ splice site of the pre-mRNA helps position the splicing machinery. The 
pseudouridine-containing U2 snRNP can then recognize the branch site through base-
pairing and in that way helps to bulge out the branch point adenosine of the pre-mRNA 
(Yu et al., 2011). Specifically, Newby and Greenbaum (2002) showed that the presence 
of pseudouridine at U2 position 35 not only stabilizes the branch-site interactions but 
also changes the orientation of the bulged adenosine relative to the U2 snRNA-intron 
duplex. These findings suggest that pseudouridine better positions the branch-site 
adenosine for recognition and subsequent activity during splicing. 
Ribosomal RNA can contain 1 – 100 pseudouridine modifications depending on the 
organism. There is a four- to eight-fold increase in the amount of pseudouridine 
incorporation in eukaryotes compared to prokaryotes. Escherichia coli contains only one 
pseudouridine in the small ribosomal subunit, while Saccharomyces cerevisiae 18S 
rRNA has up to 14 pseudouridines (Ofengand, 2002). When the pseudouridines of the 
small subunit were mapped to the three-dimensional ribosome structure, they appeared 
to be spread throughout the subunit. Conversely, within the large ribosomal subunit, 
most of the pseudouridine modifications can be mapped to functionally important regions 
of the ribosome. In E. coli, there are 10 pseudouridine modifications in the large 
ribosomal subunit, while in humans there are 55. The most highly conserved 
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pseudouridines are found in the loop of helix 69 (Ofengand, 2002). In E. coli, these 
residues, pseudouridine 1911, 1915, and 1917, help form an important bridge between 
the small and large ribosomal subunits, as well as interact with translation factors and 
tRNA during protein synthesis (O’Connor and Gregory, 2011). Pseudouridine residues 
are also frequently found to cluster around the peptidyl transferase centre. Bakin and 
Ofengand (1993) developed the N-cyclohexyl-N’-β-(4-
methylmorpholinium)ethylcarbodiimide p-tosylate (CMCT) assay for detecting the 
presence of pseudouridine in large RNAs such as the 23S rRNA of E. coli. They found 
that pseudouridine residues were present at positions 746, 2457, 2504, 2580 and 2605 
which are part of the peptidyl transferase centre and within close proximity to nucleotides 
that are directly involved in peptide bond formation (Bakin and Ofengand, 1993). This 
local clustering of pseudouridine residues may occur for structural reasons as 
pseudouridine can provide additional hydrogen bonds and confer an increased rigidity in 
the surrounding RNA structure. Additionally, Toh and Mankin (2008) demonstrated that 
E. coli strains lacking pseudouridines at positions 955, 2504, and 2580 show a strong 
increase in their susceptibility towards antibiotics targeting the peptidyl transferase 
centre of the ribosome, suggesting an intrinsic antibiotic resistance mechanism utilizing 
pseudouridine modifications. King and coworkers (2003) showed that in yeast, the 
deletion of individual pseudouridines from rRNA does not significantly affect the growth 
of the cells. However, when multiple pseudouridines were removed, synergistic effects 
were observed, resulting in impaired translation. In conclusion, the exact role 
pseudouridines play in ribosomal RNA is still under debate.  
Transfer RNAs can have numerous modified nucleotides, and up to 25% of the 
nucleosides are post-transcriptionally modified or hypermodified. The universally 
conserved pseudouridine 55 is in the TΨC stem loop of all elongator tRNAs (Sprinzl et 
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al., 1999). The only tRNAs reported that do not contain pseudouridine 55 are eukaryotic 
cytoplasmic initiator tRNAs, tRNAs for Ala, Pro, Ser, Thr, and Val from Mycoplasma 
mycoides (Samuelsson et al., 1987), and two tRNAGly species from Staphylococcus 
epidermidis that are involved in cell wall biosynthesis (Roberts, 1974). Additional 
pseudouridine modifications are commonly found in the D-arm and the anticodon stem 
loop of various tRNAs. Like the pseudouridines found in ribosomal RNA, those present 
in tRNA are not required for cell viability (Gutgsell et al., 2000; Raychaudhuri et al., 
1999). An increase in local base stacking by pseudouridines was shown by Davis and 
coworkers (1995), where NMR analysis revealed that the N1-H imino proton plays a role 
in stabilizing the conformation of the pseudouridine residue. This influence on the 
surrounding local RNA structure can be critical for tRNA binding to the ribosome and 
translational efficiency (Harrington et al., 1993; Yarian et al., 1999; Urbonavicius et al., 
2002). Pseudouridine modifications, particularly pseudouridine 55, have also been 
proposed to aid in extreme temperature resistance in both E. coli and the thermophile 
Thermus thermophilus (Kinghorn et al., 2002; Ishida et al., 2011). Notably, Ishida and 
coworkers (2011) observed an increase in Gm18, m5s2U54, and m1A58 levels when 
pseudouridine 55 was absent, signifying that pseudouridine 55 may play an important 
regulatory role in other tRNA modifications. 
1.4 Pseudouridine Synthases 
Pseudouridine synthases belong to six different families: TruA, TruB, TruD, RluA, RsuA, 
and Pus10. The first four families were characterized initially based on their sequence 
similarity (Koonin, 1996; Kaya and Ofengand, 2003). Later, the TruD family was 
identified through biochemical and gene sequencing techniques (Kaya and Ofengand, 
2003). Eventually, Pus10 was identified as a representative of a sixth family found only 
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in archaea and eukaryotes based on its weak sequence similarity to Cbf5 (Watanabe 
and Gray, 2000; Roovers et al., 2006). Each family is named after the E. coli 
representative enzyme, whereas Pus10 (not found in bacteria) is named for the human 
protein. Crystal structures have been determined for proteins belonging to each family 
(Hoang and Ferré-D’Amaré, 2001; Hoang et al., 2006; Phannachet et al., 2004; Foster et 
al., 2000; Hoang et al., 2004; Sivaraman et al., 2002; McCleverty et al., 2007). The 
amino acid sequences of all pseudouridine synthases are poorly conserved; however, 
structural comparison reveals a common catalytic core (Figure 1.2). This conserved core 
is composed of an eight-stranded mixed β-sheet with adjacent helices and loops. The 
only absolutely conserved residue, the catalytic aspartate, resides on a loop that 
occupies part of the catalytic cleft. Outside the catalytic core, a variety of additional 
domains can be found. In members of the RluA (specifically RluC and RluD) and RsuA 
families, an N-terminal extension resembles ribosomal protein S4 (Mizutani et al., 2004; 
Sivaraman et al., 2002). The enzymes belonging to the TruB family contain a C-terminal 
extension termed the PUA domain, due to its presence in pseudouridine synthases and 
in some archaeosine-transglycosylases (Hoang and Ferré-D’Amaré, 2001; Phannachet 
et al., 2004; Sabina and Soll, 2006). The RluA and RsuA families are the most closely 
related pseudouridine synthases, sharing three conserved sequence motifs (motifs I, II, 
and III). The TruB family also resembles RluA and RsuA families but lacks motif III 
(Koonin, 1996; Hoang and Ferré-D’Amaré, 2001). Structural analysis also revealed that 
members of the TruD family have a circular permutation of the order of secondary 
structural elements within the catalytic core (Ericsson et al., 2004; Hoang et al., 2004). 
Interestingly, TruD is also found in all three domains of life (Kaya and Ofengand, 2003) 
andbased on these findings it is hypothesized that enzymes of the TruD family diverged 
first from other pseudouridine synthases (Ericsson et al., 2004). Members of the TruA 
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family are also unique among pseudouridine synthase enzymes, as they are the only 
pseudouridine synthase to function as a dimer (Foster et al., 2000).  
 
Figure 1.2: Structures of representative enzymes from all six pseudouridine 
synthase families. Comparison of ribbon representations of the structures of A. TruA 
(1DJ0; Foster et al., 2000), B. TruB (1K8W; Hoang and Ferré-D’Amaré, 2001), C. RluA 
(2I82; Hoang et al., 2006), D. RsuA (1KSK; Sivaraman et al., 2002), and E. TruD 
(1SZW; Ericsson et al., 2004), all from E. coli. F. Human Pus10 (2V9K; McCleverty et 
al., 2007). All structures show the catalytic domain in the same orientation. 
A B 
C 
D 
E 
F 
TruA TruB 
RluA RsuA 
TruD Pus10 
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Within all pseudouridine synthases, the strictly conserved catalytic aspartate residue is 
found within motif II in the active site cleft (Koonin, 1996). Biochemical and structural 
studies have confirmed the importance of the conserved aspartate residue in 
pseudouridine formation. Site-directed mutagenesis in members of five pseudouridine 
synthase families has demonstrated that this residue plays a critical role in 
pseudouridine catalysis, rather than in RNA binding or substrate recognition (Huang et 
al. 1998; Conrad et al. 1999; Ramamurthy et al. 1999; Raychaudhuri et al. 1999; 
Zebarjadian et al. 1999; Del Campo et al. 2001; Kaya and Ofengand 2003; Chan and 
Huang, 2009). Structurally, the catalytic aspartate residue has been shown to be within 
close proximity to the target uridine in RNA-protein co-crystal structures (Figure 1.3; 
Phannachet et al., 2004; Hoang et al., 2006). Motif II also contains a histidine (in TruB 
family members) or an arginine (in RluA, RsuA, and TruA enzymes) that intercalates into 
the RNA strand and ensures that the target uridine flips into the active site (Hoang and 
Ferré-D’Amaré, 2001; Hoang et al., 2006). Additionally, a tyrosine (or phenylalanine in 
TruD) is conserved in a K/RxY motif and helps maintain the structural integrity of the 
active site through hydrophobic interactions by stacking against the uracil , as well as 
acting as a general base through its hydroxyl group for the proton abstraction during the 
final step of catalysis (Phannachet et al., 2005). Meanwhile, the K/R residue in this 
K/RxY motif interacts with the phosphate of the target nucleotide through a salt bridge 
possibly positioning it for catalysis (Hoang and Ferré-D’Amaré, 2001; Pan et al., 2003; 
Phannachet et al., 2004). In contrast, motif I is not involved in catalysis but instead 
functions as a support to reinforce the active site loop in motif II (Hoang et al., 2005; 
Hamma et al., 2005; Spedaliere et al., 2000). In motif III, a conserved lysine or arginine 
residue makes a salt bridge with the catalytic aspartate (Hoang et al., 2006). Although 
TruB lacks motif III, it too has an arginine present that makes a salt bridge with the 
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catalytic residue. This salt bridge has been proposed to possibly activate the catalytic 
aspartate residue as a nucleophile by deprotonating the carboxylate (Hoang and Ferré-
D’Amaré, 2001). 
 
Figure 1.3: Active site of E. coli RluA. The conserved catalytic aspartate residue is 
shown in red. The arginine residue (R62) that intercalates into the RNA (not shown here) 
is depicted in blue. Both residues belong to motif II. The conserved KxY motif is shown 
in grey and fuchsia. Arginine 165 (orange) is proposed to form a salt bridge with the 
catalytic aspartate residue. The target uridine analog (5-fluorouracil) is shown in yellow. 
 
Although much is understood about the residues involved in pseudouridine catalysis, the 
exact chemical mechanism is still not known. As all pseudouridine synthases share the 
same catalytic fold containing the conserved catalytic aspartate residue and have also 
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been proposed to have the same common evolutionary ancestor, it is very likely that 
they all share the same catalytic mechanism (Mueller, 2002). For all pseudouridine 
synthases the same chemistry is completed within their catalytic cleft. The first step is to 
disconnect the uridine base from the ribose sugar, breaking the N-C glycosidic bond. 
The base is then rotated or flipped still within the catalytic pocket and finally reattached 
to the ribose through the C5 position (Zhou et al., 2010). Gu and coworkers (1999) 
showed that TruA was able to form a covalent adduct with a 5-fluorouracil substituted 
tRNA substrate, suggesting a putative intermediate of the reaction pathway. From their 
findings it was proposed that the catalytic aspartate residue adds to the C6-position 
(Figure 1.4A) of the target uridine to form a stable Michael adduct, where the final 
product is released by hydrolysis of the ester linkage between the active-site aspartate 
and the pyrimidine ring (Gu et al., 1999). In contrast, co-crystal structures of RluA and 
TruB with 5-fluorouracil substituted RNA substrates showed that no covalent adduct 
formed and that the 5-fluoruracil was rearranged to a C-glycoside (like pseudouridine) 
(Figure 1.4B; Hoang and Ferré-D’Amaré, 2001; Hoang et al., 2006). These findings 
suggest an acylal intermediate where the catalytic aspartate attacks the C1 of the ribose 
ring. Subsequent studies revealed direct hydration of the 5-fluorouracil product rather 
than the proposed ester hydrolysis, indicating TruA, TruB, and RluA all handle 5-
fluorouracil containing substrates in the same manner (McDonald et al., 2011). A third 
mechanism has been proposed by Miracco and Mueller (2011). Based on their studies 
they suggest a glycal intermediate reaction pathway (Figure 1.4C). They found that TruB 
converts 5-fluorouridine in RNA into two isomeric hydrated products. Here, as a minor 
product of the reaction, the pentose ring is epimerized to an arabinose and this inversion  
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Figure 1.4: Proposed catalytic mechanisms of pseudouridine formation. A. 
According to the Michael addition hypothesis, the catalytic aspartate attacks the C6 
position of the uracil base. B. The aspartate attacks the C1’ position of the ribose sugar 
as suggested in the acylal intermediate mechanism. Figure adapted from Zhou et al. 
(2010). C. Glycal mechanism for pseudouridine formation; uracil extraction can be 
stepwise (top) or concerted (bottom path). Figure adapted from Miracco and Mueller 
(2011). 
A 
B 
C 
Glycal 
Intermediate 
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suggests another chemical mechanism, but strongly disfavours the Michael addition 
(Miracco and Mueller, 2011). The proposed glycal mechanism is in accordance with their 
new findings, but still awaits experimental confirmation. Therefore, the exact mechanism 
of pseudouridine formation is still contested and more analysis is needed. 
1.5 H/ACA small ribonucleoproteins 
In archaea and eukaryotes, most pseudouridine modifications are produced by RNA-
protein complexes called H/ACA small ribonucleoproteins (Kiss et al., 2010). These 
H/ACA small ribonucleoproteins (H/ACA sRNPs) contain four protein subunits, Cbf5, 
L7Ae (Nhp2 in eukaryotes), Nop10, and Gar1, along with a guide RNA (Figure 1.5). 
Archaeal H/ACA RNAs are typically composed of 60 – 75 nucleotides that fold into a 
long hairpin (Dennis and Omer, 2005). In most eukaryotes such as yeast and humans, 
the H/ACA RNA forms two hairpins each containing a pseudouridylation pocket. These 
stem loops are connected  by a single-stranded hinge (H) region (AnAnnA) and followed 
by the ACA box motif at the 3’end of the RNA (Balakin et al., 1996). Contained within the 
hairpin of the guide RNA is the pseudouridylation pocket. Here, the guide RNA can base 
pair with the target RNA sequence to position the uridine within the catalytic pocket. 
Cbf5 (dyskerin in humans), the catalytic subunit of these ribonucleoproteins, is a 
homolog of the E. coli TruB enzyme (Lafontaine et al., 1998). 
Several studies have demonstrated that Cbf5 and L7Ae directly and independently bind 
to the H/ACA guide RNA (Baker et al., 2005; Charpentier et al., 2005; Li et al., 2006). 
Cbf5 requires the presence of the ACA motif to bind to the guide RNA, but will also 
independently interact with Nop10 and Gar1 to form a stable guide-RNA independent 
subcomplex (Rashid et al., 2006). Nop10 has been shown to interact with a conserved 
stretch of amino acids close to the catalytic centre of Cbf5. In other pseudouridine 
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synthases, this region (motif I in stand-alone pseudouridine synthases; see above) helps 
stabilize the catalytic cleft, and it was hypothesized Nop10 may contribute to the overall 
stability of Cbf5’s catalytic core (Hamma et al., 2005). 
 
Figure 1.5: Organization of the H/ACA small ribonucleoprotein complex. The x-ray 
crystal structure (2HVY) of archael H/ACA small ribonucleoprotein (Li and Ye, 2006). 
The catalytic subunit Cbf5 is shown in complex with accessory proteins Gar1, Nop10, 
and L7Ae, as well as guide RNA. The catalytic aspartate (D95) is shown as red spheres. 
In yellow is the pseudouridylation pocket where substrate RNA binds to the guide RNA. 
The ACA motif is shown interacting with the PUA domain (light yellow). 
 
L7Ae 
Nop10 
Gar1 
Cbf5 
Guide 
RNA 
PUA 
domain 
ACA 
Pseudouridylation 
pocket 
Chapter 1 – Introduction   
15 
 
Although Gar1 shares many structural similarities with the RNA-binding motifs of 
bacterial translation initiation (IF2) and elongation (EF-Tu) factors, it does not directly 
interact with the guide RNA. Instead Gar1 binds to the RNA-binding thumb loop of Cbf5 
and regulates substrate turnover (Li et al., 2011; Rashid et al., 2006). Duan and 
coworkers (2009) showed that Gar1 binds to Cbf5’s thumb loop when substrate RNA is 
not present. However, once substrate RNA binds, the thumb loop has extensive 
interactions with the substrate RNA. To release the product RNA, the thumb loop 
interactions must first be broken and it was proposed that Gar1 may provide a low-
energy binding site for the thumb loop, therefore contributing to its dissociation from the 
RNA (Duan et al., 2009).  
1.6 RluA 
In prokaryotes, pseudouridine synthases typically function as stand-alone enzymes and 
consist of only a polypeptide chain without guide RNA. Two well studied examples of 
bacterial stand-alone pseudouridine synthases are E. coli TruB and RluA. RluA is 
responsible for the formation of Ψ746 in 23S rRNA and Ψ32 in tRNAPhe, tRNACys, 
tRNALeu4, and tRNALeu5. Wrzesinski and coworkers (1995) first identified RluA as a 
pseudouridine synthase responsible for the formation of Ψ746 in ribosomal RNA from E. 
coli. The surprising result was that RluA also forms Ψ32 in several tRNA species. E. coli 
RluA is a 219-amino acid protein with a molecular weight of approximately 25 kDa 
(Wrzesinski et al., 1995). The crystal structure of RluA shows a protein that adopts an 
elongated, mixed α/β fold bisected by the catalytic cleft (Figure 1.6; Hoang et al., 2006). 
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Figure 1.6: X-ray structure of E. coli RluA. The cartoon representation of RluA (2I82; 
Hoang et al., 2006) in complex with anticodon stem loop (green) shows the conserved 
catalytic cleft and the catalytic aspartate residue (red spheres). Motif I (blue), motif II 
(red), motif III (pink), and the thumb loop (grey) are also highlighted. The target uridine is 
shown in yellow. 
 
As described above, RluA contains the conserved catalytic fold found in all 
pseudouridine synthases consisting of 8 β-strands with additional flanking helices and 
loops. The co-crystal structure of RluA in complex with the anticodon stem loop (ASL) of 
tRNAPhe shows that motif II, containing the catalytic aspartate, forms a protrusion that 
U32 
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packs against the minor groove face of the ASL. Motif III was also shown to interact with 
the RNA backbone of the ASL and additionally forms part of the active site cavity (Hoang 
et al., 2006). RluA has a compact “thumb” structure which lies between strands β6 and 
β9 in the catalytic cleft and interacts with the major groove of its RNA substrate (Hoang 
et al., 2006). Like all other pseudouridine synthases, RluA requires a conserved 
aspartate residue (D64) to complete catalysis (Raychaudhuri et al., 1999). In order to 
gain a better understanding of the role of the conserved aspartate in pseudouridine 
formation, Ramamurthy and coworkers (1999) mutated RluA’s aspartate 64 to either 
alanine or cysteine and showed that this resulted in the loss of enzymatic activity. In vitro 
binding assays also demonstrated that these protein variants retainRNA binding abilities. 
Furthermore, Ramamurthy et al. (1999b) also found that substitution of conserved 
cysteine residues does not significantly alter the catalytic activity of either RluA or TruB. 
Additionally, Ramamurthy and coworkers (1999b) determined the catalytic constant (kcat) 
of pseudouridine formation by RluA to be 0.099 ± 0.003 s-1 using a full-length tRNAPhe 
transcript. When a truncated RNA substrate corresponding to the anticodon stem loop 
was used in the assay, a similar catalytic constant, 0.068 s-1, was determined (Hamilton 
et al., 2006).  
The 2904 nucleotide 23S rRNA and ~76 nucleotide tRNA substrates of RluA share very 
little structural similarity. However, all five substrates share a conserved sequence 
surrounding the target nucleotide, ΨUXXAAA, where X can be any canonical 
ribonucleotide (Raychaudhuri et al., 1999; Hoang et al., 2006). As RluA binds to a tRNA 
anticodon stem loop substrate, several major changes occur within the RNA structure as 
seen in the co-crystal structure of RluA with RNA (Figure 1.6). Residues 32, 34, and 37 
are flipped out from the helical stack of the stem loop. The empty space once occupied 
by residue 37 is filled by A36, thus making a non-sequential stacking interaction with 
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A38. Next, U33, which normally makes hydrogen bonds with backbone phosphates in 
the free tRNA structure, forms a reverse-Hoogsteen base pair with A36. Finally, A35 is 
rotated 180° and stacks underneath U33. As U32 is now flipped into the active-site of 
RluA, the gap between residues 31 and 33 is occupied with the guanidinium group from 
the side chain of arginine 62 from RluA. Arginine 62 is absolutely conserved in all 
members of the RluA, RsuA, and TruA families and most likely plays a similar role in 
substrate base-flipping. Numerous interactions between RluA’s Arginine 62 and the RNA 
substrate are made, including a bidentate salt bridge with the phosphate group of U33 
and two water-mediated hydrogen bonds with A38 (Hoang et al., 2006). This large 
structural rearrangement of the anticodon is unique to RluA. When tRNA is bound to the 
decoding centre of the ribosome, the canonical U turn conformation of the anticodon is 
maintained (Ogle et al., 2001). The phenylalaninyl-tRNA synthetase also recognizes the 
same anticodon stem loop as RluA, but only induces a small conformational distortion of 
the anticodon U turn (Goldgur et al., 1997). The U33•A36 (U747•A750 in 23S rRNA) 
reverse-Hoogsteen base pair has been shown to be critical in substrate recognition by 
RluA, and thus substrate specificity is achieved through an indirect readout of the 
protein-induced RNA structure (Hoang et al., 2006). 
1.7 TruB 
The universally conserved pseudouridine 55 in the TΨC arm of all elongator tRNAs is 
formed by TruB. Nurse and coworkers (1995) were the first to identify and characterize 
the 314-amino acid protein TruB (molecular weight of ~40 kDa) from E. coli. Similar to 
RluA, TruB adopts a mixed α/β fold in its catalytic domain, but TruB also has a distinct 
C-terminal domain called the PUA domain (Figure 1.7; Hoang and Ferré-D`Amaré, 
2001). The catalytic domain is comprised of 11 antiparallel β-strands, decorated with 
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multiple helices and loops, while the catalytic cleft bisects this fold. The PUA domain, a 
roughly spherical domain consisting of a four-stranded β-sheet and one α-helix (Hoang 
and Ferré-D`Amaré, 2001). The co-crystal structure of TruB in complex with the TΨC 
arm of tRNAPhe depicts the RNA bound by a deep cleft on the surface of the enzyme. 
Residues from strands β8, β9, and helix α4, form a thumb-like structure that pinches the 
major groove of the RNA. Two insertions differentiate TruB from Cbf5 of the H/ACA 
small RNP complexes. Insertion 2 forms the majority of the thumb-loop as described 
above, while insertion 1 forms part of the RNA binding cleft (Hoang and Ferré-D`Amaré, 
2001). In solution, the T loop of the TΨC stem loop was found to be very well ordered 
(Koshlap et al., 1999). When bound to TruB, the overall loop structure remained in this 
intact, folded conformation, indicating that TruB binds to a preorganized T-loop. 
However, when bound to TruB, nucleotides 55, 56, and 57 are flipped into the active site 
cleft, disrupting the normal helical stacking to the T arm. The role of arginine 62 in RluA 
is completed by histidine 43 in TruB which intercalates into the RNA to facilitate base-
flipping into the active site. The imidazole ring of the histidine residue is inserted into the 
T loop and stacks underneath the U54•A58 reverse Hoogsteen base pair (Hoang and 
Ferré-D`Amaré, 2001). In the intact tRNA structure this position would normally be filled 
by G18 from the D loop. Hydrogen bonds between histidine’s main chain amide and 
carbonyl groups help to stabilize its interaction with A58. U55 is forced out of the folded 
RNA structure to avoid steric clashes with the polypeptide chain C-terminal to histidine 
43. The catalytic aspartate 48 residue is positioned near the target U55 by histidine 43 
stacking under the reverse Hoogsteen base pair of U54•A58. Aspartate 48 also forms a 
salt bridge with arginine 181 which may activate the catalytic residue as a nucleophile by 
deprotonating the carboxylate (Hoang and Ferré-D`Amaré, 2001).  
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Figure 1.7: Co-crystal structure of TruB in complex with T-arm. This x-ray structure 
from Hoang and Ferré-D’Amaré (2001) (1K8W) depicts TruB (green) with truncated RNA 
(cyan) corresponding to the T-arm of tRNAPhe. Motif I (dark blue), motif II (red), and 
insertions 1 (orange) and 2 (grey) are also shown. The catalytic aspartate residue is 
shown as red spheres. Threonine 259 is shown as pink spheres. U55 is in yellow. The 
C-terminal PUA domain and bases U54 – A58 are labelled. 
 
U55 also forms a stacking interaction with tyrosine 76 in the active site of TruB. This 
same tyrosine residue is conserved in pseudouridine synthases from RluA, RsuA, TruA, 
TruB, and Pus10 families (TruD has a phenylalanine in its place). Phannachet and 
coworkers (2005) examined the role of tyrosine 76 in pseudouridine formation and 
showed that the tyrosine side chain may play a dual role within the active site. The 
phenyl ring helps to stabilize the active site by stacking against the target base and has 
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also been proposed to act as a general base through its hydroxyl group allowing for 
proton extraction during the last step of catalysis (Phannachet et al., 2005).  
Several biochemical studies have been completed to investigate the roles of conserved 
amino acids in the chemical mechanism of pseudouridine formation (Ramamurthy et al., 
1999; Ramamurthy et al., 1999b; Phannachet et al., 2005). Like in all other 
pseudouridine synthases, the catalytic aspartate is required for Ψ55 synthesis by TruB, 
but is not involved in RNA binding (Ramamurthy et al., 1999). When this aspartate was 
mutated to alanine or cysteine, TruB was still able to bind full-length tRNA substrate 
equally well as the wild-type enzyme. In an additional study, Ramamurthy et al. (1999b) 
determined the catalytic constant (kcat) of pseudouridine formation to be 0.12 ± 0.01 s
-1 
using full-length tRNAPhe as the substrate. Additional kinetic studies demonstrated that a 
truncated RNA consisting of 17 nucleotides corresponding to the T-arm of yeast tRNAPhe 
could also be used as a catalytic substrate with a similar kcat of 0.24 s
-1 (Gu et al., 1998). 
These catalytic constants are a combination of several different steps along the reaction 
pathway. Wright and coworkers (2011) demonstrated that TruB has a single-round rate 
constant of pseudouridylation (kΨ) of approximately 0.5 s
-1. 
Unique to pseudouridine synthase members of the TruB family is the C-terminal PUA 
domain. This domain is also found in other RNA-modifying enzymes such as 
archaeosine transglycosylases and RNA methyltransferases, as well as in archaeal 
sulfate reductases and bacterial and yeast glutamate kinases (Ferré-D’Maré, 2003; Hur 
et al, 2006; Aravind and Koonin, 1999; Anantharaman et al., 2002; Hallberg et al., 2007). 
As discussed briefly above, PUA domains are typically composed of several β-strands 
coiled to form a pseudobarrel, which is closed on one side by a short α-helix (Perez-
Arellano et al., 2007). In the TruB co-crystal structure from Pan et al. (2003), two RNA 
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stem-loops form a discontinuous and bulged duplex, reminiscent of the tRNA acceptor 
arm minus the CCA-3’ terminus. This duplex binds to the PUA domain of TruB through 
minor grove interactions with small polar residues of the α-helix and β2 loop (Pan et al., 
2003; Perez-Arellano et al., 2007). The crystal structure of Pyrococcus furiosus H/ACA 
small RNP revealed that Cbf5’s PUA domain recognizes the 3’-ACA trinucleotide in a 
sequence specific manner and contributes to align the H/ACA RNA within the active site 
of the enzyme (Li and Ye, 2006). The deletion of the PUA domain of Cbf5 from P. abyssi 
demonstrated the critical role this domain plays in the function of H/ACA sRNPs (Manival 
et al., 2006). Interestingly, the majority of disease-related mutations in the human Cbf5 
homolog, dyskerin, cluster in the PUA domain. These mutations cause the disease 
dyskeratosis congenita, characterized by nail dystrophy, abnormal skin pigmentation, 
bone marrow failure, and higher instances of epithelial cancers (Heiss et al., 1998; 
Knight et al., 1999; Mochizuki et al., 2004). Additionally, mutations within the PUA motif 
of the oncogene MCT-1 protein can significantly affect translation regulation (Reinert et 
al., 2006). In contrast, very little is known about the role of TruB’s PUA domain in RNA 
binding or catalysis.  
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1.8 Objectives 
Previous analysis of the chemical mechanism of pseudouridine formation has not yet 
revealed the exact steps of catalysis. Some studies have determined an overall rate of 
reaction, but no analysis of the individual steps has been conducted. As a first step 
towards gaining a better understanding of the reaction mechanism, we sought to analyse 
the kinetics of pseudouridylation by the model pseudouridine synthase RluA. The aim of 
this analysis was to determine the rate-limiting step for pseudouridine formation 
(catalysis vs. substrate binding or product release). Additionally, during catalysis the 
uracil base rotates within the catalytic pocket. By trying to exchange this base with a 
radiolabelled uracil, we could potentially provide direct evidence towards a chemical 
mechanism where no covalent adduct may be formed between the protein and 
nucleobase during catalysis. 
Currently there are several co-crystal structures of pseudouridine synthases in complex 
with RNA; however, no crystal structure has been determined for TruB or RluA using the 
full-length substrate. Both TruB and RluA have been shown to interact with short stem 
loops corresponding to tRNAPhe T-arm and anticodon stem loop, respectively (Hoang 
and Ferré-D’Maré, 2001; Hoang et al., 2006). Potentially, there could be contacts that 
are missing in the crystal structures that could contribute to binding interactions between 
the enzyme and RNA. Furthermore, preliminary studies in the Kothe lab indicate that a 
stem loop might not interact with TruB in a similar manner as the full-length tRNA in 
contrast to previous reports (unpublished studies; Gu et al., 1998). Therefore, it was our 
aim to examine whether these truncated substrates behaved similarly to the full-length 
tRNA upon binding to these pseudouridine synthases. In addition, given that 
pseudouridine and uridine differ only in the glycosidic bond attachment, it was our goal 
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to gain a better understanding of how pseudouridine synthases differentiate between 
uridine- and pseudouridine-containing tRNAs. 
The pseudouridine synthesis activity of H/ACA small RNPs requires the PUA domain of 
the catalytic subunit Cbf5 to interact with the ACA trinucleotide of the guide RNA (Li and 
Ye, 2006; Manival et al., 2006). The E. coli homolog TruB also contains a C-terminal 
PUA domain. Previously, this region has been shown to interact with an acceptor-arm 
mimic in a co-crystal structure (Pan et al., 2003; Hoang and Ferré-D’Amaré, 2001). No 
role has yet been described for TruB’s PUA domain. Therefore, the function of TruB’s 
PUA domain in substrate binding and catalysis was examined. 
 
 
 
Chapter 2 – Materials and Methods   
25 
 
Chapter 2 - Materials and Methods 
2.1 Buffers and Reagents 
Buffer TAKEM4: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 1 mM EDTA, 4 mM 
MgCl2. All nucleotide triphosphates and guanosine monophosphate for in vitro 
transcriptions were from Sigma. Radioactive [C5-3H] UTP was purchased from 
Moraveck. Inorganic pyrophosphatase was from Sigma; all other enzymes were from 
Fermentas. The fluorescent dyes 5-[2-[(2-Iodo-1-oxoethyl)amino]ethylamino]-1-
naphthalenesulfonic acid (1,5-IAEDANS) and fluorescein-5-thiosemicarbazide were 
purchased from LifeTechnologies (formerly Invitrogen). Chemicals were from VWR. 
2.2 Mutagenesis 
The QuikChange® method (Stratagene) was used for site-directed mutagenesis 
generating plasmids pET28a-TruBC58AC174AC193AT259C, pET28a-TruBΔPUA, 
pET28a-TruBD48NΔPUA, and pCA24N-RluAD64N. All reactions were carried out using 
a MyCycler™ thermo cycler (BioRad) and the conditions outlined in Table 2.1. Primers 
are given in Table 2.2. The melting temperature (Tm) for each primer was calculated 
using the Stratagene formula: 
Tm = 81.5 + 0.41(%GC) – 675/N - %mismatch 
Where N is the primer length in bases, and values for %GC and %mismatch are whole 
numbers. 
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Table 2.1: QuikChange® mutagenesis protocol for engineering 
TruBC58AC174AC193AT259C, TruBΔPUA, TruBD48NΔPUA, and RluAD64N 
Step Temperature (°C) Time  Cycles 
Initial denaturation 95 5 minutes  1 cycle 
Denaturation 95 45 seconds   
 
18 cycles 
Annealing 15 below Tm 1 minute 
Extension 68 15 minutes 
Final extension 68 15 minutes  1 cycle 
 
Table 2.2: Primers for mutagenesis reaction of TruB and RluA 
Primer name Tm (°C) Sequence 
TruBT259C sense 65.5 5’ – CCG GTG GTG AAT CTT CCG TTA TGC TCT 
TCT GTT TAC TTC AAA AAT GG – 3’ 
TruBT259C 
antisense 
65.5 5’ – CCA TTT TTG AAG TAA ACA GAA GAG CAT 
AAC GGA AGA TTC ACC ACC GG – 3’ 
RluAD64N sense 68.7 5’ – GCA GGC AGA ATC AGT GCA CCG TCT GAA 
TAT GGC TAC CAG C – 3’ 
RluAD64N 
antisense 
68.7 5’ – GCT GGT AGC CAT ATT CAG ACG GTG CAC 
TGA TTC TGC CTG C – 3’ 
TruBΔPUA sense 79.2 5‘ - GCC AAT GGA CAG TCC AGC TTA GTA GTA 
CCC GGG GGT GAA TCT TCC GTT - 3' 
TruBΔPUA 
antisense 
79.2 5' - AAC GGA AGA TTC ACC CCC GGG TAC TAC 
TAA GCT GGA CTG TCC ATT GGC - 3' 
 
Each reaction was prepared using the same PCR conditions where the final 
concentrations were 1x Pfu buffer with MgSO4, 0.4 mM dNTPs, 0.4 M forward primer, 
0.4 M reverse primer, 0.12 U/L Pfu DNA polymerase, and 0.5 to 1 g template DNA. 
As template DNA, the plasmids pET28a-TruBC58AC174AC193A, pET28a-TruB, 
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pET28a-TruBD48N (Wright et al., 2011), and pCA24N-RluA (Keio collection, Kitagawa et 
al., 2005) were used which were previously generated and purified in the Kothe lab. 
Following mutagenesis, the template DNA was digested using DpnI and samples were 
analyzed using agarose gel electrophoresis. The remaining DNA was used to transform 
E. coli DH5α cells. These cells were grown overnight at 37°C on kanamycin (pET28a 
plasmids) or chloramphenicol (pCA24N plasmids) containing LB plates. Colonies were 
picked the following day, grown overnight in the appropriate antibiotic-containing LB 
media, and plasmid DNA was isolated using a BioBasic MiniPrep kit. Plasmids were 
analysed for the correct mutation by restriction with KspAI (TruB) or Alw44I (RluA), 
followed by agarose gel electrophoresis. Sequencing by GeneWiz (South Plainfield. NJ) 
confirmed the correct mutations. These plasmids were then transformed into BL21(DE3) 
for pET28a variants and AG1 (ME5305) E. coli (Keio collection, Kitagawa et al., 2005) 
for pCA24N variants. 
2.3 Protein expression 
Recombinant hexahistidine-tagged RluA and RluAD64N were expressed from the 
pCA24N (GFP minus)-JW0057 plasmid provided by the National BioResource Project 
(NIG, Japan, Keio collection, Kitagawa et al., 2005) in AG1 (ME5305) E. coli cells in the 
presence of 50 µg/mL chloramphenicol. Kanamycin (50 µg/mL) was added to LB 
medium when TruBC58AC174AC193AT259C, TruBΔPUA, and TruBD48NΔPUA were 
overexpressed from pET28a plasmids in BL21(DE3) E. coli cells. Cultures were grown in 
500 mL LB with 50 µg/mL chloramphenicol at 37°C starting at an optical density at 600 
nm (OD600) of 0.1. Protein expression was induced once cell growth had reached 0.6 
OD600 by the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final 
concentration of 1.0 mM. Cell cultures were grown for an additional 3 hours before being 
harvested by centrifugation at 5000×g for 15 minutes using a JA-14 rotor (Beckman). 
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Cells were flash frozen in liquid nitrogen and stored at -80°C for future use. Protein 
expression was monitored by removing 1 OD600 samples and resuspending the cell 
pellets in 0.1 M Tris-HCl pH 8.5 containing 5 M urea. These samples were then analyzed 
by 12% SDS-PAGE. Gels were stained using Coomassie blue, destained and scanned.  
2.4 Protein purification 
RluA and TruB proteins were purified using the same procedure. Frozen cell pellets 
were resuspended in Buffer A (20 mM Tris-HCl pH 8.1, 400 mM KCl, 5% (v/v) glycerol, 1 
mM β-mercaptoethanol, 0.5 mM phenylmethanesulfonylfluoride (PMSF), 30 mM 
imidazole) at 5 mL/g of cells and thawed on ice while stirring. Lysozyme was added to 
the homogenous cell suspension to a final concentration of 1 mg/mL followed by 
incubation on ice for another 30 minutes. Next, sodium deoxycholate was added to the 
cell suspension at 12.5 mg/g cells. The cell suspension was incubated on ice for an 
additional 15 minutes. Cells were kept on ice and opened by sonication using 1 minute 
intervals of intensity level 6 and duty cycle at 60% for 10 minutes with a ½ inch probe. 
The suspension was then centrifuged at 30 000×g for 45 minutes in a JA-20 rotor 
(Beckman). The clear lysate was loaded onto a 5 mL Ni2+-sepharose column (GE 
Healthcare) with a flow rate of 0.5 mL/min and washed with Buffer A for approximately 
60 min at a flow of 1 mL/min until the absorbance at 280 nm (A280) returned to baseline 
(BioLogic LP Chromatography system). Proteins were eluted using a linear gradient (50 
mL at 1 mL/min) to 100% Buffer B (20 mM Tris-HCl pH 8.1, 400 mM KCl, 5% (v/v) 
glycerol, 1 mM β-mercaptoethanol, 500 mM imidazole). Peak fractions were analyzed by 
12% SDS-PAGE, pooled and concentrated using ultrafiltration (Vivaspin MWCO 10 
000). Additional purification and buffer exchange of each protein was completed using 
size exclusion chromatography. The concentrated (1.5 – 5 mL) Ni-sepharose purified 
fractions were injected onto a Superdex 75 column (XK26/100 column, GE Healthcare) 
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in Buffer C (20 mM HEPES-KOH pH 7.5, 150 mM KCl, 1mM β-mercaptoethanol, 0.5 mM 
EDTA, 5 mM MgCl2, 20% (v/v) glycerol) at a flow of 1 mL/min (BioLogic DuoFlow 
chromatography system). Peak fractions were analyzed and concentrated as before, 
aliquoted, flash frozen and stored at -80°C. The concentration of purified protein was 
determined photometrically at 280 nm using a molar extinction coefficient of 29 910 M-1 
cm-1 for RluA variants and 20 860 M-1 cm-1 for TruB variants (calculated using ProtParam 
[Gill and von Hippel, 1989]). ImageJ (version 1.41o, NIH) analysis of SDS-PAGE 
samples confirmed A280 concentration results. 
2.5 Fluorescent Labelling of TruBC58AC174AC193AT259C 
Purified TruBC58AC174AC193AT259C was diluted to a concentration of 3 µM using 1× 
labelling buffer (25 mM Tris-HCl pH 8.1, 7 mM MgCl2, 30 mM KCl). Five-fold excess of 
dye, 5-[2-[(2-Iodo-1-oxoethyl)amino]ethylamino]-1-naphthalenesulfonic acid (1,5–
IEADANS) was added to the protein, followed by incubation at room temperature with 
rocking for one hour. Unbound dye was removed by overnight dialysis at 4°C in 1000-
fold excess of 1× labelling buffer. The protein was concentrated using ultrafiltration 
(Vivaspin MWCO 10 000). Labelled protein was aliquoted, flash frozen and stored at -
80°C. The concentration of labelled protein was estimated by absorbance readings at 
280 nm. The final fluorescent label concentration was determined photometrically at 490 
nm using an extinction coefficient of 5 700 M-1 cm-1 (Life Technologies, 2010).  
2.6 tRNA Preparation 
Template DNA of E. coli tRNAPhe was first generated from the plasmid pCFO (Sampson 
et al., 1989) through PCR amplification using the following primers: 
T7 promoter sense 5’ – GCTGCAGTAATACGACTCACTATAG – 3’ 
EcotRNAPhe antisense 5’ – mUmGGTGCCCGGACTCG – 3’ 
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All PCR reactions were carried out using 1x Pfu buffer with MgSO4, 0.4 mM dNTPs, 0.4 
M T7 promoter sense primer, 0.4 M EcotRNAPhe antisense reverse primer, 0.12 U/L 
Pfu DNA polymerase, and 0.5 g pCFO template DNA. The PCR conditions are outlined 
in Table 2.3. 
Table 2.3: PCR amplification of tRNAPhe gene from the pCFO DNA template 
Step Temperature (°C) Time Cycles 
Initial 
denaturation 
95 5 minutes 1 cycle 
Denaturation 95 30 seconds 
6 cycles 
Annealing 45 (increase 1°C 
each repeat) 
30 seconds 
72 20 seconds 
Extension 95 30 seconds 
29 cycles 
50 30 seconds 
72 20 seconds 
Final extension 72 11 minutes 1 cycle 
 
The template for the 17-mer T-arm of E. coli tRNAPhe (5’ – CUU GGU UCG AUU CCG 
AG – 3’) was generated through annealing of the following primers: TSL sense 5’ – 
GCGAATACGACTCACTATAGGGCTTGGTTCGATTCCGAG – 3’ 
TSL antisense 5’ - mCmUCGGAATCGAACCAAGCCCTATAGTGAGTCGTATTCGC – 3’ 
 
For annealing, the primers (final concentration of 4 µM) were subjected to an initial 
denaturation step at 95°C for 2 minutes in 5x transcription buffer (200 mM Tris-HCl pH 
7.5, 75 mM MgCl2, 50 mM NaCl, and 10 mM spermidine), followed by annealing steps 
starting at 90°C and decreasing the temperature 0.1°C/second for 11 cycles, with a final 
incubation step at 37°C. 
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RNA corresponding to the anticodon stem loop of E. coli tRNAPhe with a deoxyribo-2-
aminopurine (2AP) substitution (5’ – GGG GAU U(2AP)A AAA UCC CC – 3’) was 
purchased from Integrated DNA Technologies (IDT). 
In vitro transcriptions were carried out using (PCR-generated) DNA template (10% v/v) 
in 5x transcription buffer (see above), 10 mM DTT, 3 mM NTPs (ATP, CTP, UTP, and 
GTP), 5 mM GMP, 0.01 U/uL iPPase, 0.3 µM T7-RNA-Polymerase, and 0.12 U/µL 
RNase inhibitor. The reaction mixture was incubated at 37°C for 16 hours. Tritium-
labelled tRNAPhe was generated by the addition of 0.1 mM [C5-3H] UTP (0.46 Ci/mmole), 
instead of 3 mM non-radioactive UTP, to the reaction mix. All radioactive in vitro 
transcriptions were carried out for 4 hours. Template DNA was digested by the addition 
of 0.002 U/µL DNase and the reaction mixture was incubated at 37°C for an additional 1 
hour. The radiolabelled tRNA was purified using Nucleobond AX20 columns (Macherey-
Nagel). Prior to purification the column was equilibrated with buffer R0 (100 mM 
Tris/acetate, 10 mM MgCl2, 15% ethanol, pH 6.3). The in vitro transcription mixture was 
first diluted to a final KCl concentration of 0.2 M with buffer R0 and buffer R3 (100 mM 
Tris/acetate, 10 mM MgCl2, 15% ethanol, 1150 mM KCl, pH 6.3) and was then loaded 
onto the column. The column was washed with buffer R1 (100 mM Tris/acetate, 10 mM 
MgCl2, 15% ethanol, 300 mM KCl, pH 6.3), and the RNA was eluted with buffer R3. 
Nonradioactive tRNA was purified using a 5mL Bio-Scale Mini DEAE anion exchange 
column (Easton et al., 2010). The column was first washed with 60 mL 2 M NaOH prior 
to purification. The tRNA was eluted from the column using a gradient from 100% Buffer 
D (50 mM sodium phosphate pH 6.5, 150 mM sodium chloride, 0.2 mM EDTA) to 100% 
Buffer E (50 mM sodium phosphate pH 6.5, 2 M sodium chloride, 0.2 mM EDTA) as 
described in Easton et al. (2010). Peak fractions were analyzed by 15% urea-PAGE, 
pooled and ethanol precipitated. The tRNA concentration was determined 
photometrically by measuring the absorbance at 260 nm using the extinction coefficient 
Chapter 2 – Materials and Methods   
32 
 
of 5 × 105 M-1 cm-1 (Peterson and Uhlenbeck, 1992). The specific activity of the 
radiolabelled tRNA was determined through scintillation counting (Tri-Carb 2800TR). 
2.7 [32P] labelling of RNA 
400 pmol 2AP-anticodon stem loop or full-length tRNA was unfolded at 90°C for 2 
minutes and flash cooled on ice. To dephosphorylate the 5’ terminus, the RNA was 
incubated with 1× NEB3 buffer and 0.1 U/L calf intestinal alkaline phosphatase (CIP; 
New England Biolabs). The reaction mixture was incubated at 50°C for 1 hour. A 
phenol:chloroform extraction was completed to remove the CIP, and the RNA was 
precipitated by the addition of 1 volume sodium-acetate and 2.5 volume ethanol. The 
RNA was resuspended in 26 µL water. The RNA was rephosphorylated by incubating 
with 1× reaction buffer A for T4 Polynucleotide Kinase, 15 U Polynucleotide Kinase 
(Fermentas) and 30 µCi [γ-32P] ATP. The reaction mixture was incubated at 37°C for 30 
minutes. The reaction was stopped by the addition of 0.5 M EDTA, pH 8.0 to a final 
concentration of 0.025 M and heat denaturation at 75°C for 10 minutes. The RNA was 
separated from unincorporated ATP by gel filtration on Sephadex G-25. A SigmaPrep 
spin column was prepared by adding 200 L of Sephadex G-25, centrifuging for 3 
minutes at 10 000 rpm and removing the supernatant. Prior to sample loading, the 
column was washed with water. The sample was then spread evenly over the sephadex 
gel, and the spin column was centrifuged for 3 min at 10,000 rpm to elute the RNA. The 
activity of the labeled RNA was determined by liquid scintillation counting. 
2.8 Preparation of fluorescein-labelled tRNA 
Purified tRNAPhe in water was oxidized with 2 mM potassium periodate for 30 minutes. 
The reaction was stopped by the addition of ethylene glycol to a final concentration of 10 
mM. Following an ethanol precipitation, the tRNA was incubated with 10 mM fluorescein-
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5-thiosemicarbazide in a 0.1 M sodium acetate solution for 16 hours in the dark. The 
RNA was precipitated by the addition of 3 M sodium acetate and ethanol. The unbound 
dye was removed via phenol extraction. The tRNA was concentrated by ethanol 
precipitation and was resuspended in water. RNA concentration was determined 
photometrically by measuring the absorbance at 260 nm using the extinction coefficient 
of 5 × 105 M-1 cm-1 (Peterson and Uhlenbeck, 1992). The dye concentration was 
determined by measuring the absorbance at 492 nm with the extinction coefficient of 85 
000 M-1cm-1 (Life Technologies, 2010). The final labelling efficiency was estimated by 
comparing the concentration of tRNA and the dye.  
2.9 Nitrocellulose filtration 
tRNAPhe was allowed to fold by incubating the RNA at 65°C, followed by slow cooling at 
room temperature. A low constant concentration of tRNAPhe (10 nM) was incubated with 
increasing concentrations of enzyme (0 – 30 µM) for 10 minutes in TAKEM4 at room 
temperature to allow for binding. The reaction mixture was filtered under vacuum 
through a nitrocellulose membrane (0.2 µm, Whatman, Maidstone, United Kingdom). 
The membrane was then washed immediately with 1 mL ice cold TAKEM4 buffer and 
dissolved in 10 mL scintillation cocktail for 30 minutes. The level of tRNA binding was 
determined through scintillation counting. The dissociation constant (KD) for tRNA 
binding was calculated by plotting the fraction of bound RNA against protein 
concentration and fitting the data to a hyperbolic function: 
Bound = Boundmax × [protein] / (KD+[protein]) 
2.10 Tritium release assay 
Previously folded [3H]tRNA was incubated with enzyme at 37°C in TAKEM4 buffer. 
Aliquots were removed at desired time points and quenched in 1 mL of 5% (v/v) 
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activated charcoal (Norit A) and 0.1 M HCl. Samples were centrifuged for 2 minutes at 
10 000 × g, and 0.8 mL of the supernatant was added to 0.5 mL 5% Norit solution in 0.1 
M HCl. Samples were centrifuged again, and 1 mL of the supernatant was filtered 
through glass wool. Finally 0.8 mL of the filtrate in 4 mL scintillation cocktail was used for 
scintillation counting to determine the amount of free tritium in solution corresponding to 
the amount of pseudouridine formed. Initial velocities were determined by completing a 
linear regression for the linear phase of pseudouridine formation. 
2.11 Quench-flow measurements 
A KinTek quench-flow apparatus was used to measure pre-steady-state kinetics, where 
1 µM (final concentration) [3H]-tRNAPhe was rapidly mixed with RluA (final concentration 
2.5 – 15 µM) in TAKEM4 buffer at 37°C. The reaction was quenched by the addition of 
0.1 M HCl after the desired reaction time (0.003 – 60 s). The amount of total [3H]-
tRNAPhe in the quenched sample was determined by scintillation counting. The amount 
of free tritium was quantified by subjecting a defined volume (120 – 220 µL) of the 
quenched sample to the tritium release assay as described above. The percentage of 
pseudouridine formation (P) was determined as a fraction of the total radioactivity 
present for each time point. The resulting time courses were fit to a one-exponential 
function to determine the apparent rate, kapp: 
P = P∞+ A × exp(-kapp × t) 
Where P∞ is the endlevel, A is the amplitude of the percentage change, t is time in 
seconds, and kapp is the apparent rate.  
These apparent rates were then plotted against enzyme concentration and fitted to a 
hyperbolic function to determine the kmax for pseudouridine formation: 
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kapp = kmax × [RluA] / (Khalf + [RluA]) (Fersht, 1998) 
2.12 Fluorescence Spectrometry and Stopped-flow measurements 
A fluorescence spectrometer (Quanta Master, Photon Technology International ) was 
used to examine equilibrium binding between fluorescently-labelled TruB and 
fluorescently-labelled tRNAPhe (FL-tRNA, see above). A sample of 3 µM TruB-1,5-
IAEDANS in TAKEM4 was excited alone and in the presence of fluorescein-tRNA at 336 
nm, and the emission spectra from 510 – 650 nm was recorded. Additionally, a solution 
of 3 µM FL-tRNA was analyzed alone by exciting the fluorophore at both 336 and 491 
nm and recording the emission spectra. All measurements were completed at 20°C with 
1 nm slit width and 1 nm step size. 
Pre-steady-state fluorescence stopped-flow measurements were completed using a 
KinTek SF-2004 stopped-flow apparatus. Here, 1 μM (final concentration) fluorescein-
labelled tRNA was rapidly mixed with 2.5 – 15 μM TruB (final concentration) at 20°C to 
ensure single-turnover conditions. Control experiments were conducted where 1 μM 
(final concentration) fluorescein-labelled tRNA was rapidly mixed with TAKEM4 buffer or 
itself. Fluorescein was excited at 480 nm and the emission was monitored using a LG-
500 nm cutoff filter. Short 15 second time courses were analyzed by fitting to a one-
exponential function: 
F = F∞ + A × exp(-kapp × t) 
Where F∞ is the fluorescence endlevel, A is the amplitude of the fluorescence change, t 
is time in seconds, and kapp is the apparent rate.  
Time courses longer than 30 seconds were fit to a one-exponential function followed by 
a linear photobleaching phase (with a slope of lin): 
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F = F∞ + A × exp(-kapp × t) + (lin × t) 
The apparent rates were plotted against enzyme concentration and fitted with a 
hyperbolic function: 
kapp = k1 + k-1 Ks/([E] + Ks) 
Where Ks is the apparent equilibrium binding constant for tRNA interacting with TruB, [E] 
is enzyme concentration, and k1 and k-1 are rate constants describing the conformational 
change in tRNA preceeding binding to TruB (see discussion). 
2.13 [14C]-Uracil Exchange 
200 pmol non-radioactive tRNA (final concentration of 600 nM) was folded in 1× 
TAKEM4 as described above prior to the start of the experiment. [
14C]-uracil (57 
mCi/mmole) was added to the tRNA to a final concentration of 500 µM. TruB wild-type or 
the catalytically inactive variant TruBD48N were added to the reaction to a final 
concentration of 10 nM. The reaction mixture was incubated at 37°C for 30 minutes. A 
phenol-chloroform extraction was used to remove the proteins, and the tRNA was 
ethanol precipitated overnight at - 20°C. The tRNA was resuspended in water and 
purified using a urea-PAGE. Gel extraction of the RNA was completed by excising the 
RNA band from the gel under UV light and incubating overnight in gel extraction buffer 
(0.5 M Ammonium acetate, 10 mM Magnesium acetate, 1 mM EDTA, 0.1% SDS). The 
sample was centrifuged 14000 rpm for 5 minutes at 4°C. The supernatant was 
transferred to a new tube, and the RNA was ethanol precipitated and finally 
resuspended in water. Samples were analyzed via scintillation counting, absorbance 
measurements at 260 nm as described above, and urea-PAGE. 
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Chapter 3 - Results 
3.1 Catalysis 
The pre-steady-state kinetic data collected on RluA was completed by myself as part of 
a larger study published in RNA (Wright et al., 2011). The undergraduate students Jaden 
Wright and Selina Dobing as well as Dr. Ute Kothe completed all other experiments 
described in the publication. 
3.1.1 Uniform Slow Catalysis  
RluA containing an N-terminal histidine-tag was overexpressed from the pCA24N(GFP 
minus)-RluA plasmid in ASKA ME3505 E. coli cells (NIG, Japan; Kitagawa et al., 2005). 
Nickel-sepharose affinity chromatography was used to purify RluA from the majority of 
other contaminating cellular components (Figure 3.1 A). Two peaks were observed. The 
largest and first peak corresponds to a large number of cellular proteins from the cell  
lysate. The second, smaller peak is consistent with the elution of the his-tagged RluA 
protein. Size-exclusion chromatography further purified, as well as rebuffered, RluA 
(Figure 3.1 B). Here, a single peak eluting at 242 - 292 mL corresponds to RluA. Peak 
fractions matching the elution profile of RluA were analysed by SDS-PAGE (Figure 3.1 
C). Bands corresponding to RluA (MW of ~ 26 kDa) were observed with no other bands 
visible. This indicates RluA was successfully purified to a purity of more than 95%. The 
concentration of RluA was determined photometrically at 280 nm. Additionally, ImageJ 
analysis of SDS-PAGE was used to confirm RluA concentration through comparison to a 
previously characterized sample of TruB. 
One approach to studying an enzyme’s mechanism is to determine the rate of the 
reaction and how it changes in response to changes in experimental parameters. At high 
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substrate concentrations, the enzyme typically becomes saturated (as all enzyme is now 
in the enzyme-substrate complex) and is limited by unimolecular steps of the reaction, 
which could correspond to conformational changes, chemical conversions, and/or 
product release. All of these steps contribute to the maximum velocity (vmax) of the 
reaction. The turnover number (kcat) can be calculated by dividing vmax by the enzyme 
concentration (Voet and Voet, 2011; Cleland, 2009). These steady-state methods  
 
Figure 3.1: Purification of wild type RluA by Ni-Sepharose and size exclusion 
chromatography. A. Chromatogram of the Ni-sepharose affinity chromatography of 6× 
his-tagged RluA. Absorbance was measured at 280 nm (left y-axis), and a linear 
gradient of 30 to 500 mM imidazole (Buffer B, right y-axis, dashed line) was used to 
elute RluA. B. Chromatogram of the size exclusion chromatography of RluA using a 
Superdex 75 column (XK26/100) to remove any impurities. C. Coomassie-stained 12% 
SDS-PAGE of peak fractions containing RluA from size-exclusion chromatography. The 
elution volume of the analyzed fractions is indicated on top of the SDS-PAGE. MWM 
represents the protein molecular weight marker. 
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provide little direct information on the different steps of the enzyme’s mechanism. kcat is 
generally assumed to represent the chemistry step, but often represents a rate-limiting 
product release step or some conformational change within the enzyme (or substrate).  
When studying steady-state kinetics the enzyme-substrate complex concentration is 
assumed to remain constant over the reaction progress. However, in the first few 
milliseconds of a reaction, the concentration of all reaction components are changing 
and this phase is termed the pre-steady-state. By studying pre-steady-state kinetics, the 
individual steps during the enzyme-substrate interaction and conversion can be 
dissected and measured directly. When excess enzyme is incubated with substrate, only 
one round of catalysis can occur; therefore, these conditions are called single turnover 
conditions. In a pseudo-first order reaction, at least 3-fold excess enzyme over substrate 
allows for the assumption that the enzyme concentration does not change during the 
reaction thus greatly simplifying kinetic analysis. Rapid-mixing devices, such as stopped-
flow and quench-flow, allow for the analysis of these reactions on such a rapid 
timescale. Thereby, the rate-limiting steps can also be identified in order to establish the 
kinetic mechanism of an enzyme (Johnson, 2005). 
In order to analyse the pseudouridylation kinetics of RluA, pre-steady-state experiments 
were completed. Here, the tritium release assay was adapted for use in quench-flow 
analysis and was completed under single-turnover conditions. The tritium release assay 
monitors the release of the radioactive tritium label from the C5 position as the new C1-C5 
glycosidic bond is formed in pseudouridine. Under these conditions, a single round of 
catalysis can occur where the tritium release assay monitors the formation of the 
enzyme-product complex as soon as it is formed. Given that the active site of RluA is 
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accessible to water, it is assumed that the released tritium can escape the active site 
cleft prior to product release (Hoang et al., 2006).  
In the quench-flow apparatus, 3- to 15-fold excess protein was rapidly mixed with [3H]-
tRNAPhe at increasing RluA concentrations for a specific length of time (0.1 to 90 
seconds). The reaction was then quenched with 0.1 M HCl to denature the protein. 
Pseudouridine formation was observed to reach 100% within 10 seconds for all 
reactions, and each RluA concentration resulted in a time course that could be fit to a 
one-exponential function in order to determine the apparent rate (kapp) of 
pseudouridylation (Figure 3.2 A). The apparent rate of pseudouridylation, kapp, was then 
plotted against the protein concentration (Figure 3.2 B). Unlike for TruB or TruA (Wright 
et al., 2011), a dependence of the kapp for pseudouridine formation on the RluA 
concentration was observed. At low concentrations of RluA, the rate of pseudouridylation 
was approximately 0.2 s-1; however this rate increased hyperbolically with RluA 
concentration reaching 0.49 ± 0.06 s-1 at a RluA concentration of 15 M. This suggests 
that RluA is limited by tRNA binding under low-enzyme conditions. By fitting these kapp 
values to a hyperbolic equation (kapp = kmax × [RluA] / (KHalf + [RluA])), a catalytic rate 
constant (kmax = kΨ) could be extrapolated from the curve and was calculated to be 0.70 
± 0.15 s-1. The KHalf was found to be 4.2 ± 2.5 µM. The previously determined catalytic 
constant, kcat, measured under multiple turnover conditions, was reported as ~0.1 s
-1 
(Ramamurthy et al., 1999), which is significantly lower than kΨ, indicating that product 
release may be limiting for RluA. Under multiple turnover conditions, each enzyme must 
release the product prior to catalyzing another reaction. If the rate of product release is 
slow, this can decrease the overall kcat of the reaction. In the quench-flow experiments, 
only a single round of catalysis is occuring which can therefore not be limited by product 
release. Notably, the pseudouridylation rate of RluA is very similar to the kΨ values 
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obtained for TruB and TruA, 0.5 ± 0.2 and 0.35 ± 0.2 s-1, respectively (Wright et al., 
2011). 
 
Figure 3.2: Rapid kinetic quench-flow analysis of pseudouridine formation by 
RluA. A. Time courses of pseudouridine formation by RluA under single turnover, pre-
steady-state conditions. Increasing concentrations of RluA (circles: 2.5 µM, triangles: 5.0 
µM, squares: 10 µM) were rapidly mixed with 1 µM [3H]-tRNAPhe in a quench-flow 
apparatus. A modified tritium release assay was used to determine the percentage of 
pseudouridine formed at each time point. Fitting with a one-exponential function (smooth 
lines) allowed for the determination of the apparent rate (kapp) of pseudouridine formation 
for each RluA concentration. B. Dependence of the apparent rate, kapp, of pseudouridine 
formation under single turnover conditions on RluA concentration. Data were fit to a 
hyperbolic function (smooth line) with a maximum rate of 0.7 ± 0.15 s-1. 
 
3.1.2 Investigating the Presence (or Absence) of a Free Uracil Base During 
Catalysis 
During pseudouridine formation, the N – C glycosidic bond is broken, the base rotated 
and reattached to the ribose sugar, all within the catalytic pocket of the pseudouridine 
synthase. Three catalytic mechanisms have been suggested (Figure 1.4). The catalytic 
aspartate residue has been proposed to form either a Michael adduct through the attack 
at C6 of the uracil base or an acylal intermediate by attacking C1’ of the ribose sugar. 
The third mechanism proposed by Miracco and Mueller (2011) implies deprotonation by 
the catalytic aspartate on the ribose C2’ position to form a glycal intermediate in either a 
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step-wise or concerted process (Figure 1.4). Some studies have hypothesized that a 
covalent bond may form between the uracil and the aspartate residue pointing towards 
the Michael adduct pathway (Hoang et al., 1998; Gu et al., 1999). During catalysis it can 
be hypothesized that the uracil base, once deattached from the ribose, may escape from 
the active site cleft if no covalent bond is formed to the uracil as proposed in the glycal 
and acylal mechanism. To investigate whether the uracil base could be exchanged 
during the reaction, we first needed to examine whether free uracil may bind to TruB 
thereby preventing tRNA substrate binding. A nitrocellulose filtration assay was designed 
where 10 nM [3H]-tRNAPhe was incubated with increasing concentrations of uracil (0 – 1 
mM). TruBD48N was added to the reaction at a concentration above the dissociation 
constant (5 µM, KD of 1.4 µM; Wright et al., 2011) to ensure binding, and the reaction 
mixture was incubated at room temperature for 10 minutes. Proteins will bind to the 
nitrocellulose membrane and if RNA forms a complex with the protein, it too will be 
retained on the nitrocellulose membrane. The protein-substrate mixture is filtered under 
vacuum and the membrane washed with cold TAKEM4 buffer. This washing step 
ensures that any unspecific interactions are broken and any unbound radioactive 
substrate is removed. Following filtration and scintillation counting, no significant 
changes were observed in the level of radioactivity retained on the filter. This constant 
level of radioactivity indicates that RNA binding is not inhibited by free uracil in solution 
and that TruB can still bind to its substrate tRNA (Figure 3.3 A).  
Next, the exchange of the uracil base within the catalytic pocket with a [14C]-labelled 
uracil from the solution was examined, which could ultimately lead to the incorporation of 
[14C]-uracil into the modified tRNA. In addition to the wild-type enzyme, control 
experiments using the catalytically inactive TruB variant, TruBD48N, or no enzyme were 
also completed. Here, it was expected that no radioactive uracil would be incorporated  
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Figure 3.3: Analysis of free uracil base exchange during pseudouridine formation 
by TruB. A. Nitrocellulose filtration assay to examine tRNA binding by TruB in the 
presence of free uracil. Increasing concentrations of uracil (0 - 1 mM final concentration) 
were incubated with [3H]-tRNAPhe (10 nM final concentration) and TruBD48N (5 µM final 
concentration) at room temperature, filtered and the radioactivity remaining on the 
nitrocelulose filter was quantified. B. Assay to observe incorporation of [14C]-uracil in 
tRNA during pseudouridylation by TruB. Unlabelled tRNAPhe (1 µM final concentration) 
was incubated with 10 nM TruB wild-type (black), TruBD48N (dark grey), or without 
enzyme (light grey) in the presence of 500 µM [14C]-uracil. Samples were collected 
following the 30 minute reaction, after phenol extraction to remove the protein, after 
ethanol precipitation of the RNA and after urea-PAGE purification of the RNA. The 
percentage of [14C]-uracil remaining in the samples was determined by scintillation 
counting. 
 
into the tRNA. Reactions were completed by incubating1 µM unlabelled tRNAPhe with 5 
µM [14C]uracil and 10 nM TruB, TruBD48N or no enzyme at 37ºC for 30 min. The 
enzyme was removed by phenol/chloroform extraction, and the tRNA was precipitated, 
purified by urea-PAGE gel extraction and quantified photometrically at 260 nm. The level 
of [14C]-uracil incorporation was determined through scintillation counting. The initial 
reaction contained 200 pmol tRNA and following phenol extraction, ethanol precipitation 
and urea-PAGE gel purification (to remove any free uracil) approximately 16 to 26% of 
tRNA was recovered. Notably, no [14C]-uracil incorporation was detected in the purified 
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tRNA when the tRNA was incubated with TruB, the catalytically inactive TruBD48N or 
without enzyme (Figure 3.3 B). 
 
3.2 RNA Binding 
3.2.1 Interaction of modified and unmodified tRNA with Pseudouridine Synthases 
A significant amount of research has gone into examining the substrate specificity 
requirements of different pseudouridine synthases. Here, the minimal structural and 
chemical differences between substrate tRNA (containing uridine) and product tRNA 
(containing pseudouridine), and their effects on binding to TruB and RluA, were 
investigated. In order to study binding interactions between RluA and tRNA, the 
catalytically inactive variant RluAD64N enzyme was prepared. Site-directed 
mutagenesis was used to create a point mutation in the pCA24N(GFP minus)-RluA 
plasmid, where the codon for the catalytic aspartate was replaced with an asparagine 
codon. Using the same conditions as for the wild-type enzyme (Fig. 3.1), RluAD64N was 
overexpressed, purified and quantified. The catalytically inactive TruBD48N variant was 
prepared previously (Wright et al., 2011). Nitrocellulose filtration assays were used to 
determine the dissociation constants (KD) of tRNA binding to RluA and TruB. Following 
filtration of the reaction mixture, any [3H]-tRNAPhe bound to the enzyme remained on the 
nitrocellulose membrane filter. The extent of binding was then quantified through 
scintillation counting. The catalytically inactive variants of RluA and TruB were used to 
determine the enzymes’ affinity for unmodified substrate, tRNA(U), while the catalytically 
active variants were used to determine the affinities for the pseudouridylated product, 
tRNA(Ψ). During incubation, the catalytically active TruB can bind and pseudouridylate 
the tRNA to form the product tRNA. Under the experimental conditions used, all the 
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tRNA will be modified by the enzyme. The RNA was melted and refolded as described in 
Materials and Methods prior to commencing the experiment. A low constant 
concentration of [3H]-tRNAPhe (10 nM) was incubated for 10 min at room temperature 
with increasing concentrations of enzyme (0 – 30 µM).  
 
Figure 3.4: Measuring TruB and RluA affinities for uridine or pseudouridine 
containing tRNA. Nitrocellulose filtration assays were conducted by incubating 10 nM 
[3H]-tRNAPhe with 0 - 30 µM (final concentrations) of (A) TruB wild-type (grey diamonds) 
or TruBD48N (black circles) (B) RluA wild-type (grey diamonds) or RluAD64N (black 
circles). The amount of tRNA bound was determined through scintillation counting of the 
nitrocellulose filters. The dissociation constant, KD, was determined by fitting the data to 
a hyperbolic function (smooth lines). Wild-type TruB and RluA were used to determine 
the affinity for product tRNA while the inactive variants were used to determine the 
affinity for substrate tRNA. 
 
The percentage of RNA bound was plotted against the enzyme concentration and fitted 
to a hyperbolic function to determine KD values (Figure 3.4). Increasing amounts of [
3H]-
tRNAPhe were retained on the filter as the protein concentration increased. The extent of 
binding reached a maximum of approximately 1.2 pmol for TruBD48N (substrate tRNA) 
and approximately 0.8 pmol for TruB wild type (product tRNA). Hyperbolic fitting of the 
binding curves revealed KD values of 3.0 ± 0.7 and 2.0 ± 0.6 µM for substrate and 
product tRNA binding to TruB, respectively. The preparation of RluAD64N had a 
concentration of only 9 µM which limited the range of possible RluAD64N concentrations 
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that could be tested in the nitrocellulose filtration assay. The product tRNA(Ψ) bound to 
RluA wild-type to a higher extent than the substrate tRNA(U) bound to RluAD64N, 
approximately 0.5 pmol and 0.25 pmol, respectively. However, due to the low RluAD64N 
concentration, a greater extent of binding might be expected at concentrations higher 
than 4.5 µM. RluA had similar dissociation constants as TruB, where substrate tRNA had 
a KD of 1.7 ± 0.4 µM and product tRNA had a KD of 4.5 ± 0.9 µM for binding to RluA. 
 
3.2.2 Interaction of Truncated tRNAs with Pseudouridine Synthases 
According to previously published results, TruB is able to form a pseudouridine in a 
truncated tRNA substrate consisting of only the T-arm (Gu et al., 1998). Although 
biochemical studies have been completed using this truncated substrate with TruB, no 
dissociation constant has been reported. In order to verify this observation, the T-arm of 
E. coli tRNAPhe was in vitro transcribed using [5-3H]-UTP to create a 17-mer radiolabelled 
substrate. Nitrocellulose filtration assays were completed to determine the extent of 
binding between TruB and the [3H]-T-arm substrate. Prior to starting the experiment, the 
RNA was folded as described previously. Increasing concentrations of TruBD48N (0 – 
30 µM) were incubated with the stem loop for 10 minutes at room temperature before 
filtration. The percentage of RNA bound was plotted against protein concentration and 
fitted to a hyperbolic function to determine KD values (Figure 3.5 A). Under these 
conditions, the full-length tRNA substrate achieved an endlevel of approximately 1.2 
pmol and had a KD of 3.0 ± 0.7 µM. The truncated T-arm substrate, however, had a 
much lower level of binding (~ 0.3 pmol) and had a KD of 2.2 ± 0.8 µM. This indicates 
that although TruB’s affinity for the truncated substrate remains relatively unchanged, 
the amount of substrate that can effectively bind is much lower than for the full-length 
substrate under these experimental conditions.  
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Figure 3.5: TruB and RluA interactions with truncated substrate tRNA. 
Nitrocellulose filtration assays of (A) TruBD48N (0 - 30 µM final concentrations) 
incubated with 10 nM full-length [3H]-tRNAPhe (black circles) or [3H]-T-arm (grey squares) 
and (B) RluAD64N (0 - 4 µM final concentrations) incubated with 10 nM [32P]-tRNAPhe 
(black circles) or [32P]-anticodon stem loop containing deoxyribose-2-aminopurine (grey 
triangles). The percentage of tRNA bound was determined through scintillation counting. 
The data were fit to a hyperbolic function to determine the dissociation constant, KD. 
 
RluA has also been shown to interact with truncated substrates comprised of the 
anticodon stem loop (ASL) of tRNAPhe (Hamilton et al. 2006, Hoang et al. 2006). No 
dissociation constant for RluA binding to its ASL substrate has been described before. 
For fluorescence experiments, we had obtained a 2-aminopurine modified anticodon 
stem loop (IDT). The original base two positions downstream of the target uridine (U32) 
was replaced with a 2-aminopurine modification. Additionally, this RNA also contained a 
deoxyribose sugar as part of the 2-aminopurine modification. To measure binding to 
RluA, both full-length tRNAPhe and the anticodon stem loop were radiolabelled with [32P]. 
Again, due to protein concentration limitations, only 0 – 4.5 µM RluAD64N were 
incubated with 10 nM of [32P]-labelled substrate. The reaction mixture was filtered and 
washed as described above. Following scintillation counting, the percentage of RNA 
bound was plotted against protein concentration and fitted to a hyperbolic function 
(Figure 3.5 B). Similar to TruB, RluA bound to the full-length substrate to a much higher 
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extent than the stem loop. The full-length tRNA substrate had a KD of 1.2 ± 0.1 µM, while 
the truncated ASL had a dissociation constant of 17 ± 13 µM. These differences may be 
due to the presence of the 2-aminopurine modification and/or the deoxyribose sugar in 
the anticodon stem loop, missing protein-RNA interactions, or the presence of 
unproductive misfolded stem loop structures. 
To examine the truncated T-arm as a possible substrate for pseudouridylation by TruB, 
Gu and coworkers (Gu et al., 1998) used a 17-mer corresponding to the T arm of wild-
type yeast tRNAPhe in the standard tritium release assay. They were able to report KM 
and kcat values, 800 nM and 0.24 s
-1 respectively, which were almost identical to those 
they determined for the full-length transcript, 780 nM and 0.24 s-1. To examine the T-arm 
as a substrate for TruB and to test these previous results, a multiple turnover tritium 
release assay was completed using 10 nM TruB and 600 nM [3H]-tRNAPhe or [3H]-T-arm. 
Prior to starting the experiment, the RNA was folded as described previously. Using the 
full-length tRNA resulted in 100% pseudouridine formation within the first 10 minutes of 
the reaction. However, following 2 hours of incubation, no significant level of 
pseudouridine formation was observed when [3H]-T-arm was included as substrate in the 
reaction (Figure 3.6 A). Next, the tritium release assay was repeated under single 
turnover conditions, where 1 µM tritium-labelled T-arm or full-length tRNA substrate was 
incubated with 5 or 15 µM TruB and the percentage of pseudouridine formation was 
determined over time (Figure 3.6 B). In contrast to the multiple turnover experiment, 
significant pseudouridine formation was observed after 1 minute for both enzyme 
concentrations, but approximately only 45% of the substrate was converted to 
pseudouridine after 90 minutes when TruB was incubated with the T-arm. The reaction  
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Figure 3.6: Tritium release assay utilizing [3H]-T-arm as the substrate for TruB. A. 
Multiple turnover tritium release assay where 10 nM TruB was incubated at 37°C with 
600 nM [3H]-tRNAPhe (black circles) or [3H]-T-arm (grey squares). B. Single turnover 
tritium release assay where 1 µM [3H]-T-arm was incubated with 5 µM (grey squares) or 
15 µM (black squares) TruB. Control assays were also completed where 5 µM (grey 
circles) or 15 µM (black circles) TruB was incubated with 1 µM full-length [3H]-tRNAPhe. 
C. Investigating the effect of temperature on pseudouridine formation in T-arm substrate. 
600 nM [3H]-tRNAPhe was incubated with 10 nM TruB at 15°C (black circles) and 20°C 
(grey circles). The truncated [3H]-T-arm was also incubated with TruB at 15°C (grey 
squares) and 20°C (black squares). The percentage of pseudouridine formation was 
determined using the tritium release assay and scintillation counting. 
 
was almost complete within the first minute of incubation when the full-length tRNA 
substrate was used. Notably, initial velocities of pseudouridine formation in the single 
turnover assays were quite different for the full-length and the truncated substrates. As 
expected, the full-length substrate was modified with a rate of ~5 nM•s-1; with 10 nM 
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enzyme this corresponds to a single-turnover rate constant kΨ of ~0.5 s
-1 which is 
identical to the rate constant measured by quench-flow measurements; however, the 
truncated substrate had an initial rate of only ~0.6 nM•s-1,  almost 10-fold slower than the 
full-length tRNA. At the moment, we cannot distinguish whether this is due to an effect 
on binding or the catalytic step or a combination of both. In the nitrocellulose filtration 
assay approximately 10% of the T-arm substrate could bind to TruB at room 
temperature. Considering the T-arm has a melting temperature of approximately 18°C as 
determined by the oligonucleotide properties calculator (Kibbe, 2007), it was 
hypothesized that the RNA may unfold at 37°C during tritium release assays. Therefore 
multiple turnover tritium release assays were completed at 15 and 20°C using both the 
truncated and full-length substrates. Also, at these lower temperatures, the T-arm still 
did not achieve any significant pseudouridine formation; however, TruB was able to form 
pseudouridine using the full-length tRNA substrate, albeit to a lower extent (Figure 3.6 
C). 
 
3.3 PUA Domain 
3.3.1 Analysis of RNA Binding Using Pre-Steady-State Stopped-Flow Kinetics 
Wright and coworkers (2011) showed that as TruB binds an unlabeled tRNA, an 
increase in the abosorbance at 260 nm can be observed. From these data, they were 
able to determine an apparent rate of binding, kapp, which surprisingly lacked any 
concentration dependence. This suggested a two-step binding mechanism (Wright et al., 
2011). To further dissect the two-step binding process, here binding interactions were 
investigated using the rapid-kinetic stopped-flow technique mixing a 3’ fluorescein-
tagged tRNAPhe (FL-tRNAPhe) substrate (described in Materials and Methods) with 
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unlabelled TruB,. RNA and dye concentrations were determined photometrically at 260 
and 492 nm, respectively. The RNA had a final concentration of 120 µM and a labelling 
efficiency of 70%. A constant low concentration of FL-tRNAPhe (0.75 µM) was rapidly 
mixed with increasing amounts of wild-type (2.5 – 15 µM) or 5 µM catalytically inactive 
TruBD48N. Following excitation of the fluorescein group at 480 nm and passing of the 
emission light through a 500 nm cutoff filter, changes in the fluorescence signal were 
monitored over time (Figure 3.7 A). A linear photobleaching phase occurred after 15 
seconds as observed in 300 s time course control experiments mixing FL-tRNAPhe with 
buffer. No change in the fluorescent signal was observed in the first 10 s when FL-
tRNAPhe was mixed rapidly with buffer or itself, but when mixed with TruB or TruBD48N a 
significant decrease in fluorescence was detected (Figure 3.7 A). The resulting time  
 
Figure 3.7: Fluorescence stopped-flow measurements to analyse TruB-tRNA 
interactions. A) Single-turnover, pre-steady-state conditions were used to analyse 
binding of fluorescein-labelled tRNAPhe by TruB. 1 µM (final concentration) of fluorescent 
tRNA was rapidly mixed with buffer (light grey), fluorescein-tRNAPhe (black), TruB wild-
type (blue, 5 µM final concentration) or the catalytically inactive TruBD48N (green, 5 µM 
final concentration). Following excitation at 480 nm, the fluorescence signal was passed 
through a 500 nm cutoff filter and recorded. The time courses were fitted to a one-
exponential function (smooth lines) to determine the apparent rate of binding, kapp. B) 
Dependence of the apparent rates of binding, kapp, of fluorescein-tRNA
Phe on the 
concentration of TruB wild-type. The data were fit with a hyperbolic function (smooth 
line). 
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courses were fit to a one-exponential function to determine an apparent rate of binding, 
kapp. As both active and catalytically inactive TruB show essentially the same time 
course, the change in fluorescence must be due to interaction of TruB with the substrate 
tRNA, but cannot be related to catalysis. More specifically, these results indicate that the 
3’ end of the tRNA interacts with TruB as the environment of the fluorophore changes. 
When the resulting apparent rates (kapp) were plotted against TruB concentration, a 
decrease in kapp with increasing TruB concentration was observed (Figure 3.7 B). In a 
typical bimolecular binding reaction, the rate will increase linearly with increasing 
enzyme concentration. Instead, here the apparent rates decreased with increasing 
enzyme concentration, and this decrease could be fit with a hyperbolic function. These 
results suggest a model where binding occurs in two steps: a slow conformational 
change occurs within the tRNA, which is then followed by rapid binding to TruB. Before 
TruB can bind, the tRNA must first undergo a conformational change, resulting in the 
binding-competent form of tRNA. At low enzyme concentrations, all of the available 
binding-competent tRNA can rapidly bind to the enzyme, giving a fast kapp. However, at 
high enzyme concentrations, the enzyme must first wait for binding-competent tRNA to 
become available to bind, as the conformational change from binding-incompetent tRNA 
to binding-competent tRNA is much slower than the binding to TruB. This model 
correlates to a slow k1 rate constant (binding-incompetent tRNA → binding-competent 
tRNA) and a fast k2 rate constant (binding-competent tRNA + TruB → TruB•tRNA). 
Fitting to a hyperbolic function can provide information on the apparent binding constant 
(Ks) which is comparable to the KD for substrate binding to TruB. Unfortunately, we found 
the Ks value could not be reliably determined as there are too few data points at low 
TruB concentrations. From the hyperbolic function, a kmin can be calculated, where kmin is 
the rate at which the tRNA conformational change (k1) occurs. The kmin was found to be 
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3.7 ± 0.5 s-1 and is in good agreement with previous results where absorbance based 
studies showed that TruB binds to unlabelled full-length tRNA in a two step process with 
an average rate of 6.0 ± 1.8 s-1 (Wright et al., 2011). 
 
3.3.2 Examining PUA Domain Deletion on Substrate Binding and 
Pseudouridylation Activity 
Previous studies have indicated that the 3’ ACA motif of the guide RNA in the H/ACA 
ribonucleoprotein particle interacts with the PUA domain of Cbf5 (Li & Ye, 2006). TruB, 
the E. coli homolog of Cbf5, also shares this PUA domain (amino acid residues 250 – 
314) and therefore may interact with the 3’ CCA terminus of tRNA molecules in a similar 
manner. To further investigate the role of TruB’s PUA domain in RNA interactions, the 
PUA domain of TruB was removed by introducing two premature stop codons at 
positions 244 and 245 using quick-change site-directed mutagenesis. The deletion of the 
PUA domain was performed both on the background of active TruB as well as the 
catalytically inactive TruBD48N variant. The resulting TruBΔPUA and TruBD48NΔPUA 
variants were purified by Ni-Sepharose and size-exclusion chromatography as described 
for the wild-type protein.  
First, the affinity of TruB lacking the PUA domain for substrate tRNA was determined. 
Towards this goal, the standard nitrocellulose filtration assay using increasing 
concentrations of TruBD48N or TruBD48NΔPUA (0 – 30 µM) and a low constant 
concentration (10 nM) of [3H]-tRNAPhe was used to determine the dissociation constant 
for the catalytically inactive ΔPUA variant protein binding to its substrate tRNA (Figure 
3.8 A ). Both TruB variants, full-length as well as TruB lacking the PUA domain, reached 
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Figure 3.8: Effect of deleting TruB’s PUA domain on tRNA binding and 
pseudouridine formation. A. Nitrocellulose filtration assay to assess the effect of PUA 
domain deletion on TruB`s ability to bind [3H]-tRNAPhe. Increasing concentrations of 
TruBD48N (closed circles) or TruBD48NΔPUA (open circles) were incubated with 10 nM 
(final concentration) of tRNA. The data were fit to a hyperbolic function (smooth line) to 
determine dissociation constants. B. Tritium release assays were used to measure 
pseudouridine formation by 10 nM TruB wild-type (closed circles) or TruBΔPUA (open 
circles) using 600 nM [3H]-tRNAPhe as substrate. 
 
the final level of binding at about 10 µM of protein. In accordance with this observation, 
fitting to a hyperbolic function revealed a KD value of 1.7 ± 0.7 µM for binding of 
substrate tRNA to the PUA deletion variant which is similar to that of the full-length 
protein (2.4 ± 0.5 µM). Interestingly, the extent of RNA binding at high protein 
concentrations for the truncated variant is approximately half of that for the wild-type 
enzyme. The exact reason for the differences in binding endlevels is not known, and 
these experiments will need to be repeated to confirm the results. 
Second, a multiple turnover tritium release assay was used to assess the 
pseudouridylation activity of the TruB variant lacking the PUA domain. Here, 10 nM 
TruBΔPUA was incubated with 600 nM [3H]-tRNAPhe, and tritium release was monitored 
over time. If the PUA domain was involved in positioning the substrate in the catalytic 
cleft, very little or no pseudouridine formation would be expected. Interestingly, wild-type 
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endlevels of pseudouridylation were observed for TruBΔPUA (Figure 3.8 B). Additionally, 
when the initial velocities for both enzymes were calculated from the initial linear 
increase in pseudouridine formation, they were found to be nearly identical, 26 ± 2.6 and 
26 ± 0.7 nM s-1 for TruB wild-type and TruBΔPUA, respectively. These results indicate 
that the PUA domain is not necessary for pseudouridine formation which is in 
accordance with the observation that the TruB variant lacking the PUA domain is 
capable of binding tRNA. 
To examine whether a fluorescence decrease is still observed when the TruBΔPUA 
variant is rapidly mixed with 3’ fluorescein-labelled tRNA, additional stopped-flow 
experiments were completed. Here, the same experimental conditions as above were 
repeated using 5 µM of the truncated TruB variants, TruBΔPUA and TruBD48NΔPUA, 
and 0.75 M fluorescein-tRNA. Unlike for the wild-type enzyme, no change in the 
fluorescence signal was observed for the truncation variants (Figure 3.9). This indicates 
Figure 3.9: Fluorescence stopped-flow analysis of PUA deletion variants 
interacting with fluorescein-tRNAPhe. Single turnover conditions were used to analyse 
substrate binding by TruB. Here, 1 µM fluorescein-tRNAPhe was rapidly mixed with 
TruBΔPUA (pink) or TruBD48NΔPUA (purple; 5 µM final concentration). For comparison, 
time courses corresponding to wild-type TruB (green) and TruBD48N (blue) are also 
shown. Time courses were fitted with a one exponential function (black lines). 
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that the 3’ acceptor stem of the fluorescein-tRNA was in fact interacting with the PUA 
domain of TruB; however based on the above results for the TruBΔPUA variant, this 
interaction is not essential for substrate binding or catalysis. 
 
3.3.3 Analysing tRNA Interactions with TruB`s PUA domain via Fluorescence 
Spectrometry 
Originally, we had planned to analyze the interaction of TruB with tRNA using 
fluorescence energy transfer between fluorescently labelled tRNA and fluorescently 
labelled TruB. As both labelled components were available, we tested here whether 
FRET could be observed indicating a proximity of the tRNA 3’ end and the TruB PUA 
domain. Fluorescence resonance energy transfer (FRET) can be used to analyse the 
distance (r) between two dyes, donor and acceptor. These dyes can be attached to two 
different interacting species to examine intermolecular interactions, but can also be 
attached to a single molecule in order to analysis intramolecular conformational 
changes. Specifically, this technique is used to analyze binding interactions as changes 
in the fluorescence resonance energy transfer reflect changes in the distance between 
two dyes. Based on previous observations, it was proposed that the 3’ terminus of a full-
length tRNA substrate could potentially come within sufficient proximity to the PUA 
domain of TruB to induce FRET between a dye attached to the 3’ end of the tRNA and a 
second dye located on the PUA domain. As described above, full-length tRNAPhe was 
labelled with a fluorescein dye at the 3’ terminus (see Materials and Methods).  
TruB was labelled using a thiol-specific dye, 5-[2-[(2-Iodo-1-oxoethyl)amino]ethylamino]-
1-naphthalenesulfonic acid (1, 5 - IAEDANS). IAEDANS has an excitation maximum of 
336 nm and an emission maximum of 490 nm. IAEDANS’s emission spectra overlaps 
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well with the excitation spectrum of fluorescein, which has an excitation maximum of 492 
nm and an emission maximum of 521 nm, giving the two dyes a Forster radius (R0) of 46 
Å (Life Technologies, 2010). First, the intrinsic cysteine residues in TruB were replaced 
with alanine to create the plasmid pET28a-EcoTruBC58A C174A C193A via site-
directed mutagenesis (completed by Jaden Wright). These cysteine residues were 
replaced by alanine in Ramamurthy et al. (1999) without any effect on the 
pseudouridylation rates of TruB. Site-directed mutagenesis was again utilized to replace 
the non-conserved threonine 259 with a new cysteine residue in the PUA domain of 
TruB to create pET28a-EcoTruBC58AC174AC193AT259C (done by Ashley Taylor 
under my supervision; see Figure 1.7). This protein was overexpressed and purified 
using the standard conditions for TruB described previously. Next, the TruB variant was 
incubated with 5–fold excess of dye for 1 hour at room temperature, dialysed to remove 
excess dye and concentrated (completed by Nathan Dawson under my supervision). 
Protein and IEADANS concentrations were determined photometrically at 280 and 336 
nm, respectively, resulting in TruB concentration of 79 µM and a 1, 5-IAEDANS 
concentration of 154 µM. The 2:1 dye:protein labelling ratio indicates that TruB could be 
labelled nonspecifically in other positions in addition to cysteine 259. 
Using the TruB variant labelled in the PUA domain and the 3’ end-labelled tRNA, 
fluorescence experiments were conducted to detect the occurrence of FRET. First, 
TAKEM4 buffer was excited at 336 nm to measure the intrinsic Raman scattering of the 
solution (Figure 3.10; buffer control). A very small peak (1 100 counts) was observed at 
373 nm which can be seen in all other spectra. Next, a solution of 3 µM TruB-1,5- 
IAEDANS (donor dye) in TAKEM4 buffer was excited at 336 nm, the excitation maximum 
for IAEDANS, and the emission spectra was recorded from 360 – 650 nm (Figure 3.10; 
donor only control).  
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Figure 3.10: Fluorescence spectra of 1,5-IAEDANS-TruB and fluorescein-tRNAPhe 
to detect Fluorescence Resonance Energy Transfer. Solutions of 3 µM 1,5 
IAEDANS-TruB and 3 µM 3’ labelled fluorescein-tRNAPhe were analysed via 
fluorescence spectroscopy. Emission scans were completed from 360 to 650 nm by 
exciting 1,5-IAEDANS-TruB alone at 336 nm (grey dashes). Fluorescein-tRNA was 
excited alone at 336 nm (black dashes) and 491 nm (continuous black line; right y-axis). 
1,5-IAEDANS-TruB and fluorescein-tRNAPhe were mixed and 1,5-IAEDANS was excited 
at 336 nm and the emission spectra recorded from 360 to 650 nm (continuous grey line). 
TAKEM4 buffer was excited at 336 nm, and the emission spectra was recorded in order 
to observe Raman scattering (black dots). 
 
The peak emission of approximately 44 000 counts occurred at 467 nm. Separately, 3 
µM of fluorescein-labelled tRNA (acceptor only control) was excited alone at 336 nm and 
the emission spectra recorded from 360 to 650 nm. This produced a peak with the 
highest emission occurring at 510 nm with counts of just over 50 000. The fluorescein-
labelled tRNA was also excited at 491 nm, the excitation maximum for fluorescein, and 
the emission spectra recorded from 510 – 650 nm. This resulted in a large fluorescence 
emission peak of over 350 000 counts at 510 nm. Subsequently, TruB-1,5-IAEDANS 
was mixed with fluorescein-tRNA at final concentrations of 3 M each. This 
concentration was chosen as it is above the dissociation constant established for TruB 
and full-length, pseudouridylated tRNA. By using active TruB, the enzyme will convert all 
substrate tRNA to pseudouridylated tRNA during the incubation resulting in the formation 
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of an enzyme-product complex which will be observed in the fluorescence spectrometer. 
Again, the donor dye (1,5-IAEDANS) was excited at 336 nm, and the fluorescence 
emission spectra were recorded from 360 to 650 nm (donor and acceptor). The 1,5-
IAEDANS fluorescence emission decreases from 44 000 counts to 38 000 counts at 467 
nm while the emission of fluorescein increases from 50 000 to 54 000 counts at 510 nm 
(Figure 3.10). Upon excitation of the donor dye in a FRET experiment, some of its 
energy is transferred to the acceptor dye resulting in acceptor fluorescence. However 
this energy transfer can only occur when the dyes are in close proximity to each other. 
Therefore a decrease in the donor dye emission and an increase in the acceptor dye 
emission reflects a decrease in the distance between the two dyes. This change in 
fluorescence emission indicates that the fluorescein at the 3’ terminus of the tRNA was 
in close proximity to the 1,5-IAEDANS attached to C259 in the PUA domain of TruB.  
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Chapter 4 - Discussion 
4.1 Uniform slow catalysis 
Pre-steady-state quench-flow analysis was used to study the catalytic step of RluA in 
pseudouridine formation. These experiments revealed a dependence of the catalytic rate 
on RluA concentration and a kΨ of 0.70 ± 0.15 s
-1. Together these results indicate that 
substrate binding limits the rate of catalysis at low RluA concentrations. However, at 
higher enzyme concentrations, this limitation is overcome and catalysis becomes rate-
limiting. Wright and coworkers (Wright et al., 2011) reported the pseudouridylation 
kinetic data for two additional pseudouridine synthases: TruB and TruA. In contrast to 
RluA, both enzymes lacked any concentration dependence in their kapp values. This 
suggests that substrate binding is not limiting for TruB or TruA. However, the kΨ values 
reported for TruB (0.5 ± 0.2 s-1) and TruA (0.35 ± 0.2 s-1) are very similar to that of RluA 
(0.70 ± 0.15 s-1). 
Multiple turnover, steady-state kinetics analysis have been completed previously for all 
three enzymes (Wright et al., 2011, Ramamurthy et al., 1999). RluA has been reported 
to have a kcat of ~0.1 s
-1, which is significantly slower than the kΨ value reported here. 
This means that the overall rate of the reaction as reflected by kcat, has a rate-limiting 
step after catalysis. Since kΨ was determined under single round conditions, only one 
round of catalysis occurs. Whereas under the steady-state conditions, multiple rounds of 
catalysis occurs. In the single round experiments, RluA only needs to bind tRNA and 
complete the catalytic step. The steady-state experiments require that RluA binds the 
substrate, completes catalysis, and then releases the product in order to complete 
another round of catalysis. Taken together, this suggests that under single round 
conditions catalysis is limiting above RluA concentrations of 5 µM, but under multiple 
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round conditions product release is limiting resulting in the lower kcat value of the overall 
reaction. This is in contrast to TruB and TruA as Wright et al. (2011) found that both 
enzymes have kcat values essentially equal to their kΨ values. As discussed above, this 
indicates that product release is not rate limiting for TruB and TruA, and catalysis itself is 
the rate-limiting step. 
Although pseudouridine synthases differ significantly in structure and sequence, they all 
share the same catalytic cleft containing the catalytic aspartate residue (Hoang et al., 
1998; Ramamurthy et al., 1999; Hamilton et al., 2005). This implies that all 
pseudouridine synthases employ the same chemical processes during catalysis. 
Interestingly, the kΨ values reported for all three enzymes are nearly identical (~0.5 s
-1) 
which supports this hypothesis. In most enzyme-catalyzed reactions, the kcat value is 
much higher, typically 102 – 106 s-1 (Voet and Voet, 2011). Compared to these values, 
the rate constant of pseudouridylation is extremely slow. Several possibilities exist that 
could help to explain such a slow rate of catalysis. First, pseudouridine synthases may 
not have had any evolutionary pressure to increase the rate of pseudouridine formation. 
Previous reports have shown that pseudouridine synthases and the pseudouridine 
modifications they create are not essential for the cell (Gutgsell et al., 2000; O’Connor 
and Gregory, 2011). It can be envisioned that the majority of the long-lived tRNA in the 
cell is modified and only the small fraction of newly transcribed tRNA needs to be 
pseudouridylated at a given time. Therefore, the slow rate of pseudouridine formation 
may not cause a bottleneck in tRNA maturation. Furthermore, if tRNA lacks 
pseudouridine modifications, it can still function and do not affect cell growth as 
described by Gutgsell and coworkers (2000). Unmodified tRNAs should not be 
detrimental to the cell as they retain the same activity and kinetic parameters in 
aminoacylation as modified transcripts in vitro (Sampson and Uhlenbeck, 1988). 
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Second, pseudouridine formation may not be the primary function of pseudouridine 
synthases. Additional proposed roles in RNA folding may be more important for the cell; 
and therefore pseudouridylation may have been selected to be slow in order to allow for 
sufficient time for RNA folding to occur (Hoang and Ferré-D’Amaré, 2001). Finally, this 
rate constant may be the possible upper limit of pseudouridylation as the chemistry 
involved in pseudouridine formation is very complex. The catalytic step itself consists of 
at least three steps that occur all within the catalytic pocket. The enzyme must first break 
the C-N glycosidic bond between the sugar and base, rotate or flip the base, and 
reattach the base with a C-C glycosidic bond. It may be with such a complicated catalytic 
mechanism that pseudouridine synthases are not able to catalyze pseudouridylation 
faster than 0.5 s-1. The first step of catalysis, cleavage of the N-C glycosidic bond, is very 
similar to the reaction catalyzed by uracil-DNA glycosylases (Stivers et al., 1999; 
Friedman and Stivers, 2010). These enzymes remove uracil from damaged DNA and 
have been reported to have kcat values of 4 – 200 s
-1 (Duraffour et al., 2007; Liu et al., 
2007). This indicates that, in theory, the first step of pseudouridine formation could 
potentially be much faster and the second or third steps are more likely rate-limiting. 
Additional quench-flow experiments could be envisioned where transient intermediates 
along the reaction pathway could be isolated and characterized to analyse the individual 
steps of catalysis. Further investigations involving pseudouridine synthases from the 
other families and other organisms are also necessary in order to establish if catalysis is 
uniformly slow for all pseudouridine synthases. 
In trying to characterize the reaction mechanism, it was found that [14C] uracil could not 
be exchanged with the uracil within the catalytic pocket of TruB during catalysis. There 
are two possibilities that could explain these observations. First, the detached uracil in 
TruB’s catalytic pocket may not be able to escape to the surrounding solution. The 
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crystal structure of TruB shows the catalytic cavity lined with several hydrophobic 
residues and the uracil base forming stacking interactions with the aromatic ring of 
Tyr76, which could render it impossible for the uracil base to dissociate from TruB 
(Hoang and Ferré-D’Amaré, 2001). The second possibility could be that the uracil base 
actually forms a covalent adduct with the catalytic aspartate residue through its C6 
position according to the Michael addition mechanism (Figure 1.4; Huang et al., 1998; 
Ramamurthy et al., 1999). If the radioactive uracil had been able to replace the 
unlabelled uracil in the tRNA strand, we would have provided evidence against this 
mechanism. Unfortunately, our current results do not support either catalytic mechanism 
as we cannot discriminate between these two possibilities. 
4.2 Product versus Substrate RNA binding 
Our binding assays clearly showed that TruB can bind to product and substrate tRNA 
equally well. The endlevels of binding in the nitrocellulose titration assay were very 
similar, as well as the determined dissociation constants, KD. TruB had KD values of 3.0 
± 0.7 and 2.0 ± 0.6 µM for substrate and product tRNA, respectively. Nitrocellulose 
filtration assays were also completed for TruB wild-type, TruBD48A, and TruBD48C by 
Ramamurthy and coworkers (1999). Here, TruB had a KD of 8.8 ± 2.0 µM for product 
tRNA, while TruBD48A had a KD of 1.6 ± 0.4 µM and TruBD48C had a KD of 1.3 ± 0.2 
µM for substrate tRNA. Furthermore, our group previously measured TruBD48N’s affinity 
for substrate tRNA to be 1.4 ± 0.3 µM (Wright et al. 2011). Hence, all results for binding 
of inactive TruB to unmodified substrate RNA are similar. Only the reported affinity for 
modified product tRNA to wild-type TruB is significantly different between Ramamurthy 
and coworkers (1999) and the values reported here. It is noteworthy that the 
experiments were conducted under slightly different buffer conditions. Ramamurthy and 
coworkers used a buffer containing 50 mM HEPES, pH 7.5 and 100 mM NH4Cl in their 
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nitrocellulose filtration binding experiments. Compared with the buffers used here (50 
mM Tris-HCl, pH 7.5, 70 mM NH4Cl, 30 mM KCl, 1 mM EDTA, and 4 mM MgCl2) it is 
noteworthy that both buffers have the same pH and a similar ionic strength. These slight 
buffer differences may or may not account for the difference. In conclusion, TruB seems 
to bind either equally well or slightly weaker to product tRNA than substrate RNA. 
Here, the dissociation constants for substrate and product tRNA binding to RluA were 
determined as 1.7 ± 0.4 and 4.5 ± 0.9 µM, respectively. The product tRNA appears to 
bind to the catalytically active RluA to a higher extent; however, the RluAD64N 
preparation limited the concentrations that could be tested with the substrate tRNA. 
Regardless, the substrate tRNA binds 2.5-fold tighter than the product tRNA (1.7 vs. 4.5 
µM). Previously, RluA wild-type has been shown to have a KD of 4.0 ± 1.1 µM when 
interacting with product tRNA (Ramamurthy et al., 1999), which is in agreement with the 
findings reported here. Additionally, the KHalf value determined here through quench-flow 
analysis was 4.2 ± 2.5 µM, which correlates to the KD value for the substrate tRNA given 
the error of the measurement. Also, RluAD64A and RluAD64C were shown to have KD’s 
of 1.8 ± 0.9 and 1.2 ± 0.5 µM, respectively (Ramamurthy et al., 1999), which is again in 
agreement with our data. Taken together, these results indicate that RluA has a slightly 
higher affinity for substrate tRNA than product tRNA. 
Notably, the KD values for TruB and RluA were found to be rather similar for both 
substrate and product tRNA. These findings indicate that the majority of the contacts 
required for binding occur within the tRNA body, and the presence of uridine and 
pseudouridine does not affect this interaction significantly. Since the affinity for product 
and substrate tRNA are so similar, it raises an interesting question of how the product 
dissociates from these enzymes. In the H/ACA ribonucleoprotein complex, it has been 
suggested that additional accessory proteins such as Gar1 may help with product 
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dissociation (Duan et al., 2009); however, in the stand-alone enzymes, which have been 
shown to be fully active in the absence of other proteins,  this would not be the case. 
Also, there is no indication that additional helicases are required in the cell to accelerate 
product release. As discussed above, the rate of product release could be rather slow for 
RluA; however, TruB has been shown to not be limited by product dissociation (Wright et 
al. 2011). A relatively fast dissociation rate, koff, could be envisioned despite the 
relatively low KD values if the association rate for product tRNA binding is also relatively 
fast (KD = koff / kon). Hence, the product tRNA could be rapidly binding and dissociating 
from TruB in a very dynamic equilibrium. To fully understand product dissociation, further 
investigations into the mechanism of product release are necessary. Lastly, in spite of 
the near identical affinities for tRNA containing uridine or pseudouridine, within the cell, 
the modified tRNA would be in demand for use in other cellular processes such as 
protein synthesis and will bind to other factors such as amino-acyl synthetases, EF-Tu 
and the ribosome. At the same time, new unmodified tRNA will be constantly generated 
through transcription. Therefore, the concentration of available free pseudouridine-
containing tRNA might be limited and would not necessarily compete with unmodified 
tRNA for binding to pseudouridine synthases. 
4.3 Truncated RNA binding 
Although truncated RNAs have been used extensively in studying pseudouridine 
synthases, particularly in structural analysis (Hoang and Ferré-D’Amaré, 2001; 
Phannachet and Huang, 2004; Hoang et al., 2006), few studies have been performed to 
understand the kinetics of these stem loops in pseudouridine formation (Gu et al. 1998, 
Hamilton et al. 2006). Gu and coworkers (1998) wanted to examine the molecular 
recognition of tRNA by E. coli TruB to determine the minimal structural requirements for 
tRNA substrates (Gu et al., 1998). They were able to show the majority of recognition 
Chapter 4 – Discussion   
66 
 
requirements for both binding and pseudouridylation lie within the T-arm of the tRNA. It 
was also reported that the 17-base oligoribonucleotide corresponding to the yeast 
tRNAPhe T-arm could serve as a substrate for pseudouridylation and results in Km and kcat 
values similar to the full-length substrate (Gu et al., 1998). So far, no data has been 
available regarding the affinity of TruB has for the truncated substrate with the E.coli 
nucleotide sequence. Therefore, a 17-mer consisting of the T-arm of E. coli tRNAPhe was 
analysed here as a substrate for TruB. Nitrocellulose filtration assays demonstrated that 
this truncated substrate could bind with a similar affinity as the full-length tRNA, 3.0 ± 0.7 
µM for full length tRNA versus 2.2 ± 0.8 µM for the T-arm, although to a much lower 
extent, 1.2 pmol bound versus 0.2 pmol bound at high protein concentrations. The nearly 
identical dissociation constants indicate that the majority of important contacts for 
substrate binding occur within the T-arm stem loop structure. The differences in binding 
endlevels may be due to misfolding of the T-arm at the experimental temperatures 
(~20°C). Using an oligonucleotide properties calculator,  the melting temperature of the 
17-mer used in the above experiments was estimated to be approximately 18°C (Kibbe, 
2007). Therefore, the T-arm may be partially unfolded at room temperature. This 
unfolded substrate might not bind to TruB or dissociates during the washing step due to 
a higher koff, thus contributing to the much lower extent of RNA binding for the truncated 
substrate. Another possible explanation for the lower extent of binding for the T-arm 
could be that during the 10 minute incubation step, the reaction has not yet reached 
equilibrium. This could be examined by incubating these samples for longer prior to 
filtering them. 
Multiple turnover tritium release assays examined whether the T-arm could be used as a 
substrate for pseudouridylation. Unlike the full-length tRNA, which reached 100% 
pseudouridine formation within 30 minutes, the truncated T-arm was unable to function 
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as a substrate and no significant pseudouridine formation was observed in multiple 
turnover assays. As this assay was completed at 37°C, it can be hypothesized that the 
majority of the substrate would be unfolded, resulting in the low levels of pseudouridine 
formation. Next, the multiple turnover assay was completed using both the T-arm and 
full-length substrates at 15 and 20°C; here only the full-length tRNA showed any 
pseudouridine formation. This reveals that, even at temperatures at or below the 
estimated melting temperatures of the T-arm, the T-arm is still an inefficient substrate for 
pseudouridylation under multiple turnover conditions (10 nM TruB incubated with 600 nM 
RNA). As full-length tRNA with a comparable KD is fully active in pseudouridine formation 
under multiple turnover conditions, it is quite surprising that not even low levels of 
modification were observed with the T-arm. One potential explanation could be that the 
T-arm binds in a non-productive fashion to TruB. Only under single turnover conditions 
could the T-arm be effectively used to form pseudouridine (Figure 3.6 B). Here, an 
endlevel of only 45% was achieved compared with 100% for the full-length substrate. 
Again, these assays were completed at a much higher temperature (37°C) than the 
reported melting temperature of the stem loop (18°C). Therefore, it is conceivable that a 
majority of the T-arm substrate would be unfolded at the assay temperatures. The higher 
level of pseudouridine formation (45%) than binding at 20°C (~ 10%) is mostly likely the 
result of the dynamic equilibrium of the folded T-arm with the unfolded T-arm. At these 
relatively high concentrations, all folded T-arm will bind to TruB and will become 
pseudouridylated. As soon as an unfolded T-arm spontaneously folds, it can therefore 
rapidly bind to TruB and can be modified, explaining a higher level of modification than 
actual binding. These findings are in stark contrast with Gu et al. (1998) where a 17-mer 
consisting of T-arm of yeast tRNAPhe was used to complete multiple turnover tritium 
release assays. 
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Our first indication that the T-arm behaved differently than the full-length substrate 
occurred during fluorescence stopped-flow with a 2-aminopurine substituted T-arm 
substrate and TruB. It was found that with increasing enzyme concentration, the 
amplitude of the fluorescent signal also increased (unpublished data). These results 
indicated TruB had a different affinity for the truncated RNA than for the full-length 
substrate. In fact, when radiolabelled with [32P] and used in a nitrocellulose filtration 
assay, this 2-aminopurine T-arm had a KD of ~ 30 µM (Ute Kothe, personal 
communication). These differences between the full-length substrate and the 2-
aminopurine T-arm substrate could be due to the presence of the deoxyribo-2-
aminopurine modification or the short T-arm itself. Upon investigating these possibilities,  
the unmodified truncated T-arm behaved significantly differently than the full-length 
tRNA in both the extent of binding and in pseudouridine formation. The discrepancies 
between our findings and those by Gu et al. (1998) may be due to several factors. The 
yeast tRNAPhe was used to prepare the 17-mer T-arm in Gu et al. (1998), while we used 
the E. coli version. However, the nucleotide sequence in the T-arm for these two species 
is nearly identical, and differs only in positions that should not influence binding. Gu and 
coworkers (1998) used a range of 0.1 – 6 µM RNA and 0.02 – 0.2 µM TruB in their 
tritium release experiments. These values are similar to the conditions used in our 
multiple turnover experiments (10 nM TruB with 600 nM RNA), but had slightly different 
buffer conditions (as mentioned above, but pH and ionic strength were comparable). 
TruB has also been shown to utilize 5-fluorouracil substituted T-arm as a substrate, 
although the concentrations used in the assay were much higher (12.5 µM TruB and 125 
µM RNA) (Spedaliere and Mueller, 2004). X-ray crystal structures clearly show TruB in 
complex with the T-arm of tRNAPhe, but these structures were produced using 
significantly larger concentrations of RNA and protein than in the tritium release assays 
(Hoang and Ferré-D’Amaré, 2001; Phannachet and Huang, 2004). Zhou and coworkers 
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(2011) also demonstrated that TruB is able to form pseudouridine in a 22-mer 
corresponding to the T-arm of tRNAPhe; however, these assays again were completed at 
RNA and TruB concentrations of 100 and 3 µM, respectively. Therefore, the data 
presented here agrees well with the majority of previously published data, but the 
differences seen with Gu et al. (1998) cannot be fully explained. 
Similar to TruB, RluA has been shown to interact with the truncated anticodon stem loop 
of its substrate tRNAPhe (Spedaliere and Mueller, 2004; Hamilton et al., 2006; Hoang et 
al., 2006). A 2-aminopurine modified anticodon stem loop (ASL) from tRNAPhe had 
previously been purchased from IDT. This RNA, along with the 2-aminopurine 
substitution, also contained a deoxyribose sugar instead of the usual ribose at this 
modification site. Originally this RNA was to be used in fluorescence stopped-flow 
studies; however, upon completion of the stopped-flow experiments an increase in the 
fluorescence signal amplitude with increasing enzyme concentrations was noted (data 
not shown). This problem indicated that there were issues in RluA binding to the 2-
aminopurine modified ASL most likely due to a lower affinity for the truncated substrate 
compared to full-length tRNA, as seen with TruB (see above). Therefore, both the ASL 
and full-length tRNAPhe were radiolabelled with [32P] in order to complete nitrocellulose 
filtration assays to examine the affinities for these RNA species. The full-length tRNA 
could bind to a much higher extent than the short stem loop. However, this difference in 
endlevel values could be due to the result of different amounts of free [32P] ATP 
contaminations in the RNA preparations. Furthermore, the dissociation constant 
determined for the full-length tRNA was 1.2 ± 0.1 µM, approximately 10-fold lower than 
the KD for the ASL (17 ± 13 µM). Several reasons can be envisioned to explain the lower 
affinity of RluA for this truncated RNA. First, these differences could be due to possible 
missing protein-tRNA interactions. However, this seems unlikely as we know from the 
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crystal structure that RluA binds to just the anticodon stem loop with the remaining tRNA 
protruding from the protein into solution (Hoang et al., 2006). Another possible 
explanation for the high KD of the ASL is the presence of unfolded stem loops in the 
solution as discussed above for TruB. These assays were completed at room 
temperature and may not have allowed for this short stem loop to remain folded properly 
(melting temperature of 18°C) (Kibbe, 2007). RluA also has a unique mechanism of 
substrate interaction where it will impose a protein-induced conformation onto possible 
RNA targets. If the RNA can adopt the correct conformation, catalysis can proceed 
(Hoang et al., 2006). It may be that with the short stem loop, important interactions within 
the tRNA itself are missing and the anticodon stem loop alone cannot form the correct 
RluA-induced conformation. Finally, the decreased affinity could also be caused by the 
2-aminopurine deoxyribose modification itself. Interestingly, the same 2-aminopurine 
deoxyribose substitution was made in the T-arm of tRNAPhe (IDT) for use with TruB. In 
this case, the affinity of [32P]-labelled 2-aminopurine T arm was also shown to be very 
low (see above). Hence, the presence of deoxyribo-2-aminopurine could in general 
affect the interaction of RNA with pseudouridine synthases.  
4.4 The function of TruB’s PUA Domain 
The pseudouridine synthase and archaeosine transglycosylase (PUA) domain can be 
found in enzymes from all three domains of life. TruB is the only family of pseudouridine 
synthases containing a PUA domain. The importance of TruB’s PUA domain was 
investigated using several biochemical techniques. First, pre-steady-state stopped-flow 
kinetics was used to examine the binding interaction between TruB and full-length tRNA. 
A 3’ end fluorescein-tagged tRNAPhe substrate, was rapidly mixed with unlabelled TruB, 
the fluorescence emission was recorded, where a decrease in the fluorescence signal 
was observed. These results indicate that as TruB and tRNA interact, the 3’ terminus of 
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the tRNA molecule undergoes a change in environment which causes the decrease in 
the fluorescence signal. This change could be due to interactions of the acceptor arm 
with the PUA domain as they come within close proximity to each other as seen when 
the TruB crystal structure is modeled in association with full-length tRNA (Figure 4.1; 
Hoang and Ferré-D’Amaré, 2001). In the tRNA guanine transglycosylase structure from 
Ishitani and coworkers (2003), they note that the basic residues in the PUA domain 
specifically interact with the backbone phosphates in the acceptor stem of the tRNA 
(Ishitani et al., 2003). Although little sequence similarity between TruB and archaeosine 
tRNA guanine transglycosylase is detectable, TruB’s Arg307 is in a homologous position 
in its PUA domain to Arg578 in the transglycosylase structure and could have a similar 
role in binding the acceptor stem. It is interesting to note that the fluorescence signal 
decreased during the stopped-flow experiments. Typically, the fluorescence is expected 
to increase as the fluorophore forms new interactions with the protein and is removed 
from the solvent (Lakowicz, 2006). Instead the decrease may be caused by the 
fluorophore, which was initially interacting with the acceptor arm of the tRNA, is replaced 
by the PUA domain of TruB, causing the fluorescein to interact (and be quenched) by 
the surrounding solvent. 
 
Chapter 4 – Discussion   
72 
 
Figure 4.1: Model of TruB in complex with full-length tRNAPhe. A. The model is 
based on the crystal structures of TruB (green; 1K8W; Hoang and Ferré-D’Amaré, 2001) 
and full-length yeast tRNAPhe (blue; 4TNA; Hingerty et al., 1978). The crystal structure of 
TruB contained the structure of the T-arm (see Fig. 1.7) which was aligned here to the T-
arm of full-length tRNA. Position 259 on the back surface of TruB’s PUA domain is 
depicted in fuchsia and was used for fluorescent labelling. The 3’ CCA terminus of tRNA 
used for labelling is shown in orange. The target uridine 55 is shown in yellow. B. 
According to this model and without assuming additional conformational changes, the 
distance between the 3’ terminus of tRNA (orange) and position 259 in TruB (fuchsia) 
would be approximately 30 Å. 
30.3 Å 
B 
A 
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Interestingly, the kapp values for binding decrease as enzyme concentration increases. 
This dependence suggests a model where substrate binding occurs in two steps. Here, 
a pool of tRNA substrate undergoes a slow conformational rearrangement into binding-
competent tRNA, which can rapidly bind to TruB. At low enzyme concentrations, only the 
available binding-competent tRNA binds to TruB resulting in a fast rate of binding. This 
occurs because at TruB concentrations below the KD (~3 µM) only a small fraction of the 
tRNA will bind. However, with increasing enzyme concentrations, more tRNA must be 
converted to the binding-competent form before it can interact with TruB, as TruB will 
bind to all of the tRNA and not just a small fraction when the TruB concentration is above 
the KD. This results in a decrease in the rate of binding as the reaction is now limited by 
the slow conformational change of the tRNA. As shown in Figure 4.2, this model is 
characterized by a slow conformational change (k1) and a fast binding event (k2). The 
rate constant of the tRNA conformational change (binding-incompetent tRNA to binding-
competent tRNA) is k1, whereas the reverse conformational change is described by the 
rate constant k-1. Assuming the equilibrium (Keq) between the two tRNA species favours 
the binding-incompetent tRNA (large Keq = k-1/k1), only a small pool of binding-competent 
tRNA is present at the start of the reaction. As only the actual binding step is observed in 
our experiments, the apparent rate of binding at high TruB concentrations, i.e. complete 
binding, describes the rate-limiting tRNA conformational change (k1). This kmin (= k1), as 
determined by hyperbolic fitting, was found to be 3.7 ± 0.5 s-1. This value is in good 
agreement with Wright et al. (2011) where it was shown that TruB could bind to tRNA at 
an average overall rate of 6.0 ± 1.8 s-1. Substrate binding was also revealed to occur in 
two steps, as the kapp remained constant over the protein concentration range examined 
(Wright et al., 2011), but the signal was noisier than in the fluorescence experiments 
described here and the TruB concentrations were slightly higher. This could explain why 
the apparent rates of binding seemed to remain constant low enzyme concentrations. 
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Figure 4.2: Model of TruB binding to substrate tRNA. Stopped-flow analysis of 
fluorescein-tRNA binding to TruB revealed a two-step binding mechanism. The first step 
consists of a slow conformational rearrangement within the tRNA from a binding-
incompetent form (tRNA) to a binding-competent form (tRNA*) which is characterized by 
the rate constants k1 and k-1 followed by the rapid second step where binding-competent 
tRNA (tRNA*) binds to TruB (rate constants k2 and k-2 for association and dissociation, 
respectively). 
 
In the canonical L-shape structure of tRNA, modifications within the T-arm and D-arm, 
specifically pseudouridine 55 and Gm18, help create the elbow of tRNA where the T-arm 
and D-arm interact thereby anchoring the acceptor side to the anticodon side (Bjork, 
1995). Large conformational changes within the full-length tRNA have been shown to 
occur upon association with tRNA guanine transglycosylases which modifies G15 in the 
D-arm (Ishitani et al., 2003). However, the crystal structure of TruB in complex with the 
T-arm reveal only marginal changes between the enzyme bound and free stem-loop 
structures (Hoang and Ferré-D’Amaré, 2001). No crystal structure information is 
available for the full-length tRNA substrate in complex with TruB. Therefore, based on 
the findings presented here, it could be envisioned that the tRNA must first break the 
interactions between the T- and D-arms in order for uridine 55 to be flipped out into 
TruB’s active site. Our data would suggest that tRNA spontaneously switches between 
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the binding-incompetent and binding-competent conformations, for example by 
loosening the interaction between D- and T-arm, and that only this form can bind to 
TruB. This also implies that TruB does not actively change the tRNA conformation, but 
rather relies on a dynamic equilibrium of conformations of the free tRNA to select the 
binding-competent form. 
In order to establish the importance of TruB’s PUA domain in tRNA substrate 
interactions, the PUA domain of TruB was removed via site-directed mutagenesis. The 
tRNA binding properties, as well as the pseudouridylation kinetics of the TruBΔPUA 
variants, were analysed. Nitrocellulose filtration assays showed that the determined KD 
values were nearly identical to the wild-type values. Additionally, the endlevel and rate of 
pseudouridine formation by TruBΔPUA was essentially the same as for the wild-type 
protein. These results suggest that the PUA domain is dispensable for tRNA binding and 
catalysis. However, when stopped-flow experiments were repeated using the truncated 
TruB variants and 3’-labelled tRNA, no change in the fluorescence signal was observed 
(Figure 3.9). This indicates that the labelled 3’ end of the tRNA interacts with the PUA 
domain of TruB, giving rise to the fluorescence changes observed with wild-type TruB. 
This is clear evidence for a role of the PUA domain in binding the acceptor stem of 
tRNA. However, although the fluorescence data suggest an interaction between TruB’s 
PUA domain and the substrate tRNA, this interaction is not essential for tRNA binding or 
catalysis. As the dissociation constant reflects the free energy of binding, it seems 
counterintuitive that the deletion of the PUA domain, which removes contacts between 
the tRNA and protein, does not affect the KD. However, as shown in the binding 
experiments with the truncated tRNA, the majority of contacts are found in the catalytic 
domain of the protein and the T-arm of the RNA. This suggests that the contacts 
between the tRNA’s 3’ end and the PUA domain are relatively weak. In this case, 
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removing the rather weak contacts with the PUA domain does not significantly affect the 
energy of binding and therefore the KD. Notably, previous reports have indicated that the 
PUA domain is not essential for the function of glutamate 5-kinase or tRNA guanine 
transglycosylase (Perez-Arellano et al., 2005; Sabina and Soll, 2006). Furthermore a 
sequence alignment of 100 bacterial TruB amino acid sequences reveals very little 
sequence conservation within the PUA domain (Appendix 1). In fact, Chlamydia 
trachomatis, a gram-negative human pathogen, does not have a PUA domain in its TruB 
sequence. These findings further underline our finding that the PUA domain is not 
essential for TruB’s pseudouridylation activity.  
Finally, substrate tRNA binding to TruB was analysed using fluorescence spectrometry. 
As before, a fluorescein label was attached to the 3’ end of tRNAPhe, while TruB was 
fluorescently-labelled at position C259 in the PUA domain with 1,5-IAEDANS. When 1,5-
IAEDANS was excited at 336 nm in the presence of fluorescein-tRNA, FRET occurred 
as shown by the decrease in 1,5-IAEDANS emission at 467 nm and an increase in the 
fluorescein emission at 510 nm. This is in particular remarkable as we know from 
previous experiments that the fluorescence of fluorescein-tRNA decreases when it binds 
to unlabelled TruB. However, this fact together with the fact tRNA labelling is incomplete 
(not 100%) prevents us from quantifying the FRET efficiency and thus determining the 
distance between the fluorophores. Therefore, these experiments merely demonstrate 
that the tRNA 3’ end and the PUA domain of TruB come in proximity (distance 
comparable to the R0). In future, additional control experiments are required to measure 
the fluorescence emission of labelled TruB in the presence of unlabelled tRNA as well as 
the fluorescence of labelled tRNA in the presence of unlabelled protein. 
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4.5 Future perspectives 
To further understand the chemical mechanism involved in pseudouridine formation, the 
next step would be to isolate and quantify the abasic intermediate that occurs during 
catalysis. This will provide information on the first chemical step, N-C glycosidic bond 
breakage. If glycosidic bond cleavage is fast compared to the subsequent steps, an 
abasic intermediate should build up within a short time window. This intermediate could 
be isolated using quench-flow experiments and short time courses of reaction. 
Potentially, mass spectrometry could be used to identify such an intermediate. 
Furthermore, the nature of a potential covalent intermediate could be investigated by 
isolating it after quench-flow experiments to find out whether the catalytic aspartate 
attacks the uracil base or the ribose sugar. From the results provided here, we already 
know that all three steps in catalysis occur with an overall rate of approximately 0.5 s-1. 
These future experiments could provide information on the individual steps of catalysis 
and hopefully determine the rate-limiting step. Additional analysis of the remaining 
pseudouridine synthase families will provide insight into whether the catalytic step is 
uniformly slow for all pseudouridine synthase enzymes. 
This study has demonstrated that the pseudouridine synthases TruB and RluA have very 
similar affinities for their product and substrate tRNA targets. As they bind equally well to 
both uridine and pseudouridine containing tRNA, we could next analyse product release. 
The koff rate constant of tRNA dissociation could be determined in stopped-flow 
experiments. Towards this aim, one could incubate the fluorescein-tagged tRNA with 
catalytically active TruB prior to rapidly mixing with an excess of unlabelled tRNA in the 
stopped-flow. Here, the dissociation of the labelled tRNA will be observed by a 
fluorescence increase while the unlabelled tRNA will bind to the free TruB preventing it 
from re-binding to labelled tRNA. Therefore, the change in the fluorescence signal over 
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time allows for the determination of the rate constant of dissociation. Similar experiments 
could be completed using the catalytically inactive TruB variant, which would provide 
information on the koff for the substrate tRNA. 
Unlike for Cbf5, TruB’s PUA domain seems to be unnecessary for enzyme function. The 
obvious next question is: Why has this protein evolved to have such a domain? Previous 
studies have reported that TruB may function as a RNA chaperone within the cell 
(Gutgsell et al., 2000). Expression of the catalytically inactive TruBD48N from a plasmid 
was sufficient to restore the ability of the knockout TruB E. coli strain to compete with 
wild-type cells. Although no pseudouridylation occurred at position 55 in the tRNA of 
these cells, they were still able to grow as efficiently as the wild-type strain (Gutgsell et 
al., 2000). Mutations in the human homolog dyskerin occur in or around the PUA domain 
and result in the X-linked disease dysteratosis congenita (Knight et al., 1997). 
Additionally, these mutations in the PUA domain have been shown to interfere with the 
interaction of Cbf5 with the assembly factor Shq1 during RNP biogenesis (Grozdanov et 
al., 2009; Li et al., 2011). Lin and Momany (2003) also demonstrated that the fungus 
Aspergillus nidulans shows growth defects when a valine to phenylalanine mutation 
occurs within the PUA domain of the Cbf5 homolog SwoC1 revealing the PUA domain 
plays an important role in enzyme function which might be unrelated to its 
pseudouridylation activity. Therefore, the next step in studying the PUA domain would be 
to express the truncated TruB variant in the E.coli TruB knockout strain and to examine 
the fitness of the cells. If expression of the TruBPUA protein in the knockout strain 
cannot rescue this strain in competition with wild-type cells, this may indicate that the 
PUA domain is important for cellular fitness and could be involved in RNA-binding or 
protein-protein interactions within the cell. Immunoprecipitation assays could be 
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envisioned where an antibody specific for TruB could be used to “pull-down” additional 
interaction partners from wild-type cells.  
4.6 Conclusion 
This thesis presents the first pre-steady-state rapid kinetic analysis of RluA giving 
valuable insight into the pseudouridylation mechanism of E. coli pseudouridine 
synthases. We showed that the rate constant of pseudouridylation is approximately 0.7 
s-1 for RluA. Together with analysis of TruB and TruA, we were able to show that all 
three pseudouridine synthases have a uniformly slow catalytic step (Wright et al., 2011). 
Investigations of the other pseudouridine synthases representing other families and 
organisms will determine if catalysis is uniformly slow for all pseudouridine synthases. 
We also demonstrated that truncated tRNAs may not function as well as biochemical 
substrates as previously thought. Precaution must be taken whenever using these 
substrates for kinetic measurements. Additionally, we found that TruB and RluA bind 
similarly to product and substrate RNA, therefore the kinetic analysis of product release 
is needed for these stand-alone pseudouridine synthases. Furthermore, the kinetic 
analysis of substrate binding revealed that TruB relies on a spontaneous and slow 
conformational change in free tRNA in order to rapidly bind to a binding-competent form 
of tRNA. Finally, we demonstrated that TruB’s PUA domain, like those of glutamate 5-
kinase and archaeosine guanine transglycosylase, is not essential for substrate binding 
or the catalytic function. In summary, this study contributes significantly to our 
understanding of the molecular mechanisms and kinetics of tRNA interaction with the 
bacterial pseudouridine synthases TruB and RluA. 
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Figure A-1: Alignment of TruB bacterial sequeneces. 100 bacterial TruB sequences aligned using GenDoc. Black shows 100% 
conserved, dark grey shows mostly conserved, light grey marginally conserved and white is not conserved. Species number and 
name are in order as they appear in the alignment below. 
P62190|TRUB_MYCTU Mycobacterium tuberculosis 
P60340|TRUB_ECOLI Escherichia coli (strain K12) 
Q57612|TRUB_METJA Methanocaldococcus jannaschii 
Q9Z8L9|TRUB_CHLPN Chlamydia pneumoniae 
Q8ZBC4|TRUB_YERPE Yersinia pestis 
Q6F7I5|TRUB_ACIAD Acinetobacter sp. (strain ADP1) 
A3N007|TRUB_ACTP2 Actinobacillus pleuropneumoniae serotype 5b (strain L20) 
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A4SJR7|TRUB_AERS4 Aeromonas salmonicida (strain A449)  
O66922|TRUB_AQUAE Aquifex aeolicus 
A1R520|TRUB_ARTAT Arthrobacter aurescens 
A1K7B7|TRUB_AZOSB Azoarcus sp. (strain BH72) 
Q6G5F5|TRUB_BARHE Bartonella henselae 
Q1LSL0|TRUB_BAUCH Baumannia cicadellinicola subsp. Homalodisca coagulata  
Q8YEB5|TRUB_BRUME Brucella melitensis biotype 1 (strain 16M / ATCC 23456 / NCTC 10094) 
P59876|TRUB_BRUSU Brucella suis biovar 1 (strain 1330)  
P57456|TRUB_BUCAI Buchnera aphidicola subsp. Acyrthosiphon pisum (strain APS) 
Q8K9H3|TRUB_BUCAP Buchnera aphidicola subsp. Schizaphis graminum 
Q89AF6|TRUB_BUCBP Buchnera aphidicola subsp. Baizongia pistaciae (strain Bp) 
Q62KL1|TRUB_BURMA Burkholderia mallei 
Q482T7|TRUB_COLP3 Colwellia psychrerythraea (strain 34H / ATCC BAA-681)  
C3PH13|TRUB_CORA7 Corynebacterium aurimucosum (strain ATCC 700975 / DSM 44827 / CN-1) 
P60343|TRUB_CORDI Corynebacterium diphtheriae  
Q8FPB3|TRUB_COREF Corynebacterium efficiens 
A4QEY6|TRUB_CORGB Corynebacterium glutamicum (strain R) 
Q4JV56|TRUB_CORJK Corynebacterium jeikeium (strain K411)  
A9KBM3|TRUB_COXBN Coxiella burnetii (strain Dugway 5J108-111) 
Q4AAX7|TRUB_COXBU Coxiella burnetii 
Q0TCU3|TRUB_ECOL5 Escherichia coli O6:K15:H31 (strain 536 / UPEC) 
P60341|TRUB_ECOL6 Escherichia coli O6  
Q7MBB8|TRUB_GLOVI Gloeobacter violaceus  
Q4QK43|TRUB_HAEI8 Haemophilus influenzae (strain 86-028NP)  
A5UBU2|TRUB_HAEIE Haemophilus influenzae (strain PittEE) 
A5UF28|TRUB_HAEIG Haemophilus influenzae (strain PittGG) 
Q0I3P3|TRUB_HAES1 Haemophilus somnus (strain 129Pt) 
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Q2SML1|TRUB_HAHCH Hahella chejuensis (strain KCTC 2396) 
C4K3E8|TRUB_HAMD5 Hamiltonella defensa subsp. Acyrthosiphon pisum (strain 5AT) 
Q5QTZ0|TRUB_IDILO Idiomarina loihiensis (strain ATCC BAA-735 / DSM 15497 / L2-TR) 
Q5X1C5|TRUB_LEGPA Legionella pneumophila (strain Paris) 
Q5ZRV6|TRUB_LEGPH Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) 
Q5WT38|TRUB_LEGPL Legionella pneumophila (strain Lens) 
Q65SL2|TRUB_MANSM Mannheimia succiniciproducens (strain MBEL55E) 
P62189|TRUB_MYCBO Mycobacterium bovis 
A1KMD6|TRUB_MYCBP Mycobacterium bovis (strain BCG / Pasteur 1173P2) 
Q73VW3|TRUB_MYCPA Mycobacterium paratuberculosis 
A0PQD9|TRUB_MYCUA Mycobacterium ulcerans (strain Agy99) 
B4RMB1|TRUB_NEIG2 Neisseria gonorrhoeae (strain NCCP11945) 
Q9JTX5|TRUB_NEIMA Neisseria meningitidis serogroup A 
Q820P2|TRUB_NITEU Nitrosomonas europaea 
Q3J9B8|TRUB_NITOC Nitrosococcus oceani (strain ATCC 19707 / NCIMB 11848) 
Q5YSE0|TRUB_NOCFA Nocardia farcinica 
Q8YWR1|TRUB_NOSS1 Nostoc sp. (strain PCC 7120 / UTEX 2576) 
Q9CMQ7|TRUB_PASMU Pasteurella multocida (strain Pm70) 
Q7MAY1|TRUB_PHOLL hotorhabdus luminescens subsp. laumondii (strain TT01) 
Q6LUJ0|TRUB_PHOPR Photobacterium profundum 
Q6A7P0|TRUB_PROAC Propionibacterium acnes (strain KPA171202 / DSM 16379) 
Q1IF41|TRUB_PSEE4 Pseudomonas entomophila (strain L48) 
Q3IJ75|TRUB_PSEHT Pseudoalteromonas haloplanktis (strain TAC 125) 
Q4ZNR4|TRUB_PSEU2 Pseudomonas syringae pv. syringae (strain B728a) 
Q1MN41|TRUB_RHIL3 Rhizobium leguminosarum bv. viciae (strain 3841) 
Q21H63|TRUB_SACD2 Saccharophagus degradans (strain 2-40 / ATCC 43961 / DSM 17024) 
Q57JI1|TRUB_SALCH Salmonella choleraesuis 
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Q5PLB2|TRUB_SALPA Salmonella paratyphi 
Q8ZLT2|TRUB_SALTY Salmonella typhimurium 
B8CKH5|TRUB_SHEPW Shewanella piezotolerans (strain WP3 / JCM 13877) 
Q31W45|TRUB_SHIBS Shigella boydii serotype 4 (strain Sb227) 
Q82K56|TRUB_STRAW Streptomyces avermitilis 
B1VYN2|TRUB_STRGG Streptomyces griseus subsp. griseus (strain JCM 4626 / NBRC 13350) 
Q8DU15|TRUB_STRMU Streptococcus mutans 
Q04KA7|TRUB_STRP2 Streptococcus pneumoniae serotype 2 (strain D39 / NCTC 7466) 
Q5M4G2|TRUB_STRT2 Streptococcus thermophilus (strain ATCC BAA-250 / LMG 18311) 
Q47RU8|TRUB_THEFY Thermobifida fusca (strain YX) 
Q9KU78|TRUB_VIBCH Vibrio cholerae 
Q5E7L3|TRUB_VIBF1 Vibrio fischeri (strain ATCC 700601 / ES114) 
Q87M04|TRUB_VIBPA Vibrio parahaemolyticus 
A7Z4T7|TRUB_BACA2 Bacillus amyloliquefaciens (strain FZB42) 
Q9KA80|TRUB_BACHD Bacillus halodurans 
Q0SM48|TRUB_BORAP Borrelia afzelii (strain PKo) 
Q5HU02|TRUB_CAMJR Campylobacter jejuni (strain RM1221) 
P58063|TRUB_CAUCR Caulobacter crescentus 
B0BB81|TRUB_CHLTB Chlamydia trachomatis serovar L2b (strain UCH-1/proctitis) 
A5N845|TRUB_CLOK5 Clostridium kluyveri (strain ATCC 8527 / DSM 555 / NCIMB 10680) 
Q0TPS0|TRUB_CLOP1 Clostridium perfringens (strain ATCC 13124 / NCTC 8237 / Type A) 
Q895J5|TRUB_CLOTE Clostridium tetani 
Q3Z7U5|TRUB_DEHE1 Dehalococcoides ethenogenes (strain 195) 
Q3YSC6|TRUB_EHRCJ Ehrlichia canis (strain Jake) 
Q7U330|TRUB_HELHP Helicobacter hepaticus 
Q03QT7|TRUB_LACBA Lactobacillus brevis (strain ATCC 367 / JCM 1170) 
Q038M8|TRUB_LACC3 Lactobacillus casei (strain ATCC 334) 
Appendix                   . 
122 
 
Q92C26|TRUB_LISIN 
 
Listeria innocua  
B0JJJ5|TRUB_MICAN Microcystis aeruginosa (strain NIES-843) 
Q98Q19|TRUB_MYCPU Mycoplasma pulmonis (strain UAB CTIP) 
Q04ED7|TRUB_OENOB Oenococcus oeni (strain BAA-331 / PSU-1) 
A5D2S3|TRUB_PELTS Pelotomaculum thermopropionicum (strain DSM 13744 / JCM 10971 / SI) 
Q1RIG2|TRUB_RICBR Rickettsia bellii (strain RML369-C) 
A7X1Q5|TRUB_STAA1 Staphylococcus aureus (strain Mu3 / ATCC 700698) 
Q8NWZ0|TRUB_STAAW Staphylococcus aureus (strain MW2) 
P65856|TRUB_STRA3 Streptococcus agalactiae serotype III 
Q8CWM3|TRUB_THEEB Thermosynechococcus elongatus (strain BP-1) 
O83859|TRUB_TREPA Treponema pallidum (strain Nichols) 
P45142|TRUB_HAEIN Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) 
 
